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Hospital-acquired infections (HAIs) are a serious health concern worldwide. Currently in 
New Zealand, around one in ten patients admitted to hospitals will acquire an infection 
while receiving treatments for other diseases in hospitals. One of emerging strategies to 
reduce the risk of HAIs is to apply metallic copper on the commonly touched items, 
providing sustained protection against microbial contamination. This is owing to the fact 
that bacterial pathogens are rapidly killed on copper surfaces through a process termed 
contact killing. However, the mechanisms of contact killing still remains elusive. 
 
Research in our laboratory aims to elucidate the mechanism of copper-mediated contact 
killing and investigate the probable overlapping antimicrobial resistances to copper and 
antibiotics. Based on a previous experimental evolution, we found several different 
responses potentially conferring copper resistance: increased tolerance to copper ions, 
decreased pyoverdine production and elevated mutation rate. Also, consistent to our 
expectation, evolved copper-resistant strains showed altered levels of resistance to 
antibiotics such as tobramycin. 
 
Next, two unique approaches of experimental evolution were used to assess the potential 
of bacteria to develop resistance to ionic copper, involving colony-to-colony transfer and 
broth-to-broth transfer. Specifically, P. fluorescens SBW25 and P. aeruginosa MPAO1 were 
subjected to passage of sub-lethal concentrations of copper ions on LB agar and in LB 
broth. After several transfers, the evolved strains exhibited an increase of minimal inhibitory 
concentration of copper ions. 
 
Taken together, data presented in this thesis implicates potential evolutionary mechanisms 
of bacterial resistance to metallic copper, and further suggest the probable evolution of 
overlapping bacterial resistances to copper and antibiotics. Primary data were obtained for 
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Amp     ampicillin 
bp       base pairs 
Cb       carbenicillin 
CF       cystic fibrosis 
CFU     colony forming unit 
DNA     deoxyribonucleic acid 
dNTP    deoxyribo nucleotide tri-phosphate 
EPA     the United States Environmental Protection Agency 
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g        gram 
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h        hour 
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mM      millimolar 
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MRSA    methicillin-resistant Staphylococcus aureus 
Nal      nalidixic acid 
Nm      neomycin 
OD      optical density 
PBPs    penicillin-binding proteins 
PCR     polymerase chain reaction 
Pen      penicillin 
ROS     reactive oxygen species 
s        seconds 
Str       streptomycin 
Tet       tetracycline 
Tob      tobramycin 
TBE     tris-borate-ethylenediamine tetraacetic acid 
UV      ultraviolet 
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WHO    world health organization 
WT      wild type 
ºC       degrees Celsius 
µg       microgram 
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µm      micrometer 




Table of Contents 
 
Abstract .............................................................................................................................. 2 
Acknowledgements ........................................................................................................... 3 
List of Abbreviations ......................................................................................................... 4 
Table of Contents .............................................................................................................. 6 
List of Figures .................................................................................................................. 10 
List of Tables .................................................................................................................... 12 
CHAPTER ONE: INTRODUCTION................................................................................... 13 
1.1 Hospital-acquired infections ..................................................................................... 13 
1.2 Application of copper bactericidal properties in HAIs prevention ............................ 14 
1.2.1 The antimicrobial efficacy of copper ................................................................. 14 
1.2.2 The potential of copper-containing antimicrobial materials in reducing the risk 
of HAIs ........................................................................................................................ 15 
1.3 The mechanism of metallic copper-induced cell death ........................................... 17 
1.3.1 The current understanding of copper-mediated contact killing ......................... 17 
1.3.2 The toxicity of copper ion .................................................................................. 17 
1.3.3 The copper ions burst releasing hypothesis ..................................................... 19 
1.4 The potential of bacteria to develop overlapping resistance to copper and 
antibiotics ....................................................................................................................... 21 
1.4.1 The mechanism and medical use of antibiotics ................................................ 21 
1.4.2 The antibiotic resistance crisis .......................................................................... 22 
1.4.3 The mechanism of co-selection of heavy metals and antibiotics ..................... 24 
1.5 The mechanism of copper homeostasis in bacteria ................................................ 25 
1.6 Specific objectives of this study ............................................................................... 27 
CHAPTER TWO: MATERIALS AND METHODS ............................................................ 30 
2.1 Bacterial strains and growth conditions ................................................................... 30 
2.2 Laboratory media ..................................................................................................... 32 
2.3 Bacterial susceptibility to copper sulfate in P. fluorescens ...................................... 33 
7 
 
2.4 Determining the minimal inhibitory concentration of antibiotics in P. fluorescens .. 34 
2.5 Measurement of growth kinetics in M9 minimal medium and LB medium 
supplemented with tobramycin ...................................................................................... 35 
2.6 Assay for bacterial fitness ........................................................................................ 35 
2.7 Pyoverdine production measurement ...................................................................... 36 
2.8 Measurement of bacterial mutation rate .................................................................. 36 
2.9 Electroporation technique ........................................................................................ 37 
2.9.1 Preparation of electrocompetent Pseudomonas aeruginosa cells ................... 37 
2.9.2 Transformation of Pseudomonas aeruginosa by electroporation ..................... 37 
2.10 Experimental evolution of bacterial resistance to ionic copper for Pseudomonas 
aeruginosa and Pseudomonas fluorescens .................................................................. 38 
2.10.1 Broth-to-broth transfer in LB broth .................................................................. 38 
2.10.2 Colony-to-colony transfer on gradient LB agar plates .................................... 39 
2.10.2.1 Preparation of gradient LB agar plates supplemented with copper 
sulfate ...................................................................................................................... 39 
2.10.2.2 Serial passages on gradient LB agar plates ............................................ 40 
2.11 Standard PCR and agarose gel electrophoresis ................................................... 41 
CHAPTER THREE: RESULTS ......................................................................................... 43 
3.1 Evolving P. fluorescens SBW25 on the surfaces of metallic copper ....................... 43 
3.1.1 Examining bacterial susceptibility to copper ions ............................................. 44 
3.1.2 Measuring pyoverdine production by the evolved strains ................................ 45 
3.1.3 Using fluctuation test to determine mutation rate of the evolved strains .......... 47 
3.2 Exploring antimicrobial resistances to antibiotics and copper ................................. 49 
3.2.1 Using agar dilution method to determine the minimal inhibitory concentration 
(MIC) of antibiotics ...................................................................................................... 49 
3.2.2 Determining bacterial resistance to tobramycin in broth medium ..................... 51 
3.2.3 Measuring fitness of the evolved strains relative to the wild-type ancestor ..... 53 
3.3 Evolution of bacterial resistance to ionic copper ..................................................... 54 
3.3.1 Broth-to-broth transfer ....................................................................................... 54 
8 
 
3.3.2 Colony-to-colony transfer using the gradient-plate method .............................. 60 
CHAPTER FOUR: DISCUSSION ..................................................................................... 67 
4.1 Evolution of bacterial resistance to metallic copper ................................................ 67 
4.2 Overlapping antimicrobial mechanisms of antibiotics and metallic copper ............. 68 
4.3 Evolution of bacterial resistance to ionic copper ..................................................... 69 
CHAPTER FIVE: CONCLUSION AND FUTURE RESEARCH ........................................ 71 
5.1 Evolved strains show different functional traits associated with the evolution of 
copper resistance ........................................................................................................... 71 
5.2 Resistance to metallic copper is overlapped with resistance to tobramycin. .......... 71 
5.3 Bacteria has evolved increased resistance to copper ions through evolutionary 
experiment ...................................................................................................................... 71 
5.4 Future research ........................................................................................................ 72 
APPENDICES .................................................................................................................... 74 
Appendix 1. Plate photos for copper MIC tests. ............................................................ 77 
Appendix 2. Pyoverdine production (RFU) of evolved strains after 24-hour and 48-
hour growth in LB medium. ............................................................................................ 78 
Appendix 3. Pyoverdine production (RFU) of evolved strains after 24-hour in LB 
medium. .......................................................................................................................... 79 
Appendix 4. Pyoverdine production (RFU) of evolved strains after 24-hour and 48-
hour growth in KB medium. ............................................................................................ 80 
Appendix 5. Pyoverdine production (RFU) of evolved strains after 24-hour growth in 
KB medium. .................................................................................................................... 81 
Appendix 6. Rates of mutation in evolved control strains and copper treatment 
experimental populations (C1 to C8 and D1 to D8) at 320th transfer and in their 
common ancestor SBW25. ............................................................................................ 82 
Appendix 7. Plate photos for antibiotic MIC tests. ......................................................... 85 
Appendix 8. Plate photos for tobramycin MIC tests....................................................... 87 
Appendix 9. Growth kinetics of wild-type SBW25 and evolved control strains in LB 
medium ........................................................................................................................... 89 
Appendix 10. Growth kinetics of wild-type SBW25 and evolved copper treatment 
strains in LB medium. ..................................................................................................... 91 
9 
 
Appendix 11. Growth kinetics of wild-type SBW25 and evolved control strains in M9 
minimal salt medium ...................................................................................................... 92 
Appendix 12. Growth kinetics of wild-type SBW25 and evolved copper treatment 
strains in M9 minimal salt medium ................................................................................. 94 
Appendix 13. Fitness of evolved strains in LB medium. ................................................ 95 
Appendix 14. Fitness of evolved strains in LB medium with 2 μg/ml tobramycin.......... 96 
Appendix 15. PCR verification of the integration of Mini-Tn7 element carrying lacZ 
fusion in P. aeruginosa MPAO1. .................................................................................... 97 
Appendix 16. Blue colonies formed by the 30th evolutional SBW25 strain and the 
40th evolutional MPAO1 strain from broth-to-broth transfer.......................................... 99 
Appendix 17. Plate photos for copper MIC tests for the evolved SBW25 strains from 
broth-to-broth transfer. ................................................................................................. 101 
Appendix 18. Plate photos for copper MIC tests for the evolved MPAO1 strains from 
broth-to-broth transfer .................................................................................................. 102 
Appendix 19. Distribution of colonies on gradient LB agar plates with ionic copper. .. 103 
Appendix 20. Plate photos for copper MIC tests for the evolved SBW25 strains from 
colony-to-colony transfer. ............................................................................................. 105 
Appendix 21. Plate photos for copper MIC tests for the evolved MPAO1 strains from 
colony-to-colony transfer. ............................................................................................. 107 






List of Figures 
Figure 1.1. A comparison of antibacterial activity between copper and three other 
materials. ............................................................................................................. 15 
Figure 1.2. Worldwide hospital trials assessing the antimicrobial efficiency of copper 
alloys ................................................................................................................... 16 
Figure 1.3. SEM image of the honeycomb-like structures of E. hirae cells. .............. 19 
Figure 1.4. Current model of the tentative events in contact killing ........................... 20 
Figure 1.5. The copper ion burst releasing (CIBR) model of contact killing .............. 21 
Figure 1.6. Trends of total antimicrobial resistance by common antibiotics .............. 24 
Figure 1.7. A proposed model of copper homeostasis in P. fluorescens SBW25. ..... 26 
Figure 1.8. A proposed model of copper homeostasis in P. aeruginosa PAO1 ......... 27 
 
Figure 2.1. Gradient LB agar plate consisting of two agar layers .............................. 40 
 
Figure 3.1. Outline of the mutation accumulation experiment. .................................. 43 
Figure 3.2. Dynamic changes in bacterial resistance to copper ................................ 44 
Figure 3.3. Representative plate photos for copper MIC tests. ................................. 45 
Figure 3.4. Pyoverdine production (RFU) by the evolved strains when grown in LB 
medium ................................................................................................................ 46 
Figure 3.5. Pyoverdine production (RFU) by the evolved strains when grown in KB 
medium ................................................................................................................ 47 
Figure 3.6. Rates of mutation in evolved strains at 320th transfer and in their common 
ancestor SBW25 ................................................................................................. 48 
Figure 3.7. Representative photos for the sensitivity of P. fluorescens strains to 
tobramycin ........................................................................................................... 51 
Figure 3.8. Growth kinetics of wild-type SBW25 and the evolved strains (A: copper 
treatment strains; B: control strains) in LB medium with tobramycin. ................ 52 
Figure 3.9. Growth kinetics of wild-type SBW25 and the evolved strains (A: copper 
treatment strains; B: control strains) in M9 minimal salt medium with tobramycin.
 ............................................................................................................................. 53 
Figure 3.10. Fitness of evolved strains in LB medium with and without 2 μg/ml 
tobramycin ........................................................................................................... 54 
Figure 3.11. Yield of P. aeruginosa MPAO1 and P. fluorescens SBW25 grown in LB 
broth supplemented with varying concentrations of copper sulphate ................ 55 
Figure 3.12. Outline of experimental evolution by broth-to-broth transfer ................. 56 
11 
 
Figure 3.13. Verification of P. fluorescens SBW25 and P. aeruginosa MPAO1 strains 
from the 30th and 40th broth-to-broth transfer, respectively ................................ 56 
Figure 3.14. PCR verification of each strain line from broth-to-broth transfer ........... 57 
Figure 3.15. Colony-to-colony transfer performed on gradient LB agar plates ......... 63 
Figure 3.16. Verification of P. fluorescens SBW25 and P. aeruginosa MPAO1 strains 
obtained from the 10th and 20th colony-to-colony transfer, respectively ............. 64 





List of Tables 
Table 2.1. List of bacterial strains and plasmids used in this study ........................... 30 
Table 2.2. List of laboratory media used in this study ................................................ 33 
Table 2.3. List of antibiotics used in this study ........................................................... 34 
Table 2.4. List of forward primers and reverse primers .............................................. 41 
Table 2.5. Sequence of primers used in this study .................................................... 41 
Table 2.6. Reagents of PCR reaction ......................................................................... 42 
Table 2.7. Standard PCR setup .................................................................................. 42 
 
Table 3.1. A summary of phenotypic analysis of wild-type bacteria P. fluorescens 
SBW25 and the evolved strains. ......................................................................... 48 
Table 3.2. Minimal inhibitory concentrations (MICs, μg/ml) of antibiotics for the evolved 
strains and mutants derived from SBW25 .......................................................... 50 
Table 3.3. Minimal inhibitory concentrations (MICs) of copper sulphate for the evolved 
strains by broth-to-broth transfer.. ....................................................................... 59 
Table 3.4. Minimal inhibitory concentrations (MICs) of copper sulphate for the evolved 







CHAPTER ONE: INTRODUCTION 
1.1 Hospital-acquired infections 
Due to the increased use of medical devices, hospital-acquired infections (HAIs), also 
referred to as healthcare-associated infections, have become a global complication that 
are yet to be solved. In the United States hospitals, the Centers for Disease Control (CDC) 
estimates that HAIs are the cause of 1.7 million infections and more than ninety thousand 
associated deaths per annum (Al-Tawfiq et al., 2014). In other developed countries, it is 
estimated that around 10% patients acquire HAIs during their hospital admission, with 
significantly higher risks in surgical intensive care units (ICU) and in neonates (World 
Health Organization., 2011). According to the statistics published by the World Health 
Organization (WHO), the prevalence rate of HAIs in New Zealand is around 12%. HAIs are 
a serious risk to not only hospitalised patients but also healthcare workers and other visitors 
through dermal contact. 
 
In addition to significant mortality and morbidities, HAIs account for substantial costs to patients 
and healthcare system as HAIs prolong the length of hospital stay of patients and their recovery 
time. HAIs pose a greater risk to vulnerable individuals, such as premature babies, elderly 
patients and people with immunodeficiencies resulting from certain chronic diseases. As 
estimated by Graves et al. (2003), the annual cost to HAIs in New Zealand is around $136.61 
million in total, including both medical and surgical admissions. 
 
Over a half of these infections can be prevented at an early stage and, consequently, HAIs 
prevention has been a top priority in healthcare institutions. Normally, to mitigate the 
acquisition of HAIs, two approaches are implemented: (1) vertical approaches targeting 
specific pathogens, such as active surveillance testing and decolonisation; and (2) 
horizontal broad-based approaches, including maintenance of the hospital environment 
cleaning, disinfection and hand hygiene and minimisation of the overuse of invasive 
medical devices (Septimus et al., 2014). However, the compliance rate of hand hygiene is 
only about 40%, and hand hygiene alone cannot fully counter HAI acquisition (Pittet et al., 
2000). 
 
Currently, contact surfaces in hospitals, such as doorknobs, faucets and bed rails, are 
made of materials deficient in antibacterial activity, such as stainless steel, chrome and 
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plastics. However, the study by Sharpe et al. (2011) has shown that microbes can persist 
on these dry inanimate surfaces for several months even after deep cleaning and be 
transmitted through contact between patients, visitors and staff. Thus, an emerging HAIs 
prevention strategy is applying inherently antimicrobial properties to commonly touched 
surfaces within the clinical setting and one of such examples is metallic copper and its 
alloys. Copper can rapidly eliminate a wide range of pathogenic bacteria through the 
‘contact killing’ process, thus providing protection between routine cleaning and 
decontamination and further decreasing HAIs. 
 
1.2 Application of copper bactericidal properties in HAIs prevention 
1.2.1 The antimicrobial efficacy of copper 
Copper with its atonic number 29 is an essential trace element for living organisms. Copper 
has been used by human civilisations for thousands of years owing to its excellent strength, 
malleability and thermal conductivities. The medical application of copper, either alone or 
in copper complexes, can be dated back to between 2600 and 2200 B.C and was first 
recorded in an Egyptian medical text, the Smith Papyrus, in which it was mentioned that 
copper was used to sterilise chest wounds and disinfect drinking water. In more recent 
eras, the antimicrobial property of copper was supported by the evidence that copper 
miners appeared to be immune to the cholera that broke out in Paris in the 19th century 
and arthritis in Finland (Dollwet, 1985). Additionally, copper and copper compounds were 
used to heal postoperative wounds and treat other infections, ranging from tuberculosis to 
skin problems, throughout human history (Dollwet, 1985; Borkow, 2014). 
 
In New Zealand, the $1 and $2 coins in current circulation are made of an aluminium-
bronze alloy mainly composite of copper. In addition to performance advantages such as 
corrosion resistance, durability and recyclability, copper is selected as coinage material as 
it is more sanitary than other metals. A research conducted in 2016 showed that the 
American penny consisting of a copper-plated zinc core exhibited a significant reduction in 
microbial infections associated with human hands as compared to the modern New 
Zealand 10 and 50 cent coins containing steel and nickel (Vriesekoop et al., 2016). 
 
In 2008, after being supported by extensive antimicrobial efficacy testing, copper was 
officially approved as the first and only antibacterial metallic agent by the American 
Environmental Protection Agency (EPA) due to its inherent ability to eliminate several 
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disease-causing pathogens within hours, even including the hospital multiple-drug-
resistant nosocomial pathogens methicillin-resistant Staphylococcus aureus (MRSA) and 
vancomycin-resistant Enterococci (VRE) (Salgado et al., 2013). 
 
1.2.2 The potential of copper-containing antimicrobial materials in reducing the 
risk of HAIs 
As copper surfaces can kill harmful bacteria, there is now great hope that copper, with its 
self-sanitising properties, can aid in reducing the nosocomial infections acquired in 
hospitals and therefore cross-contamination as a supplement to existing hand hygiene 
and disinfection regimens. To implement its use in the healthcare sector, copper can be 
mixed with other metals to optimise the final properties of the resulting alloy. 
 
An initial laboratory study performed at the University of Southampton, UK, indicated that 
the copper-base coating on the surface of hospital facilities is effective against the 
following pathogens: Enterobacter aerogenes, Escherichia coli O157:H7, MRSA, 
Pseudomonas aeruginosa, Staphylococcus aureus and VRE. The study showed that 
more than 99.9% of those bacterial strains were killed within two hours under typical 
indoor conditions. As an example, as shown in Figure 1.1 (adapted from 
https://www.copperalloystewardship.com/), copper provided a defence against MRSA at 
room temperature and humidity, while two silver-containing materials from two different 
manufacturers showed no antimicrobial efficacy under the same condition; moreover, 
stainless steel, which was included as the negative control, proved no different. 
 
Figure 1.1. A comparison of antibacterial activity between copper and three other 
materials. This figure was adapted from the EPA Registration Copper Stewardship Site 
(https://www.copperalloystewardship.com/), showing the trend of colony forming units 
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(CFU) of MRSA per coupon over a period of 350 minutes. (copper, brown line; sliver-
containing coating A, red line; silver-containing coating B, green line; stainless steel, blue 
line). 
 
Based on the inherent antimicrobial ability of copper and copper alloys in the laboratory, a 
number of clinical trials have been conducted or are now ongoing around the world; they 
aim to evaluate the efficacy of copper alloys in sustaining hospital cleaning levels and 
reducing the incidence of HAIs. Figure 1.2 shows countries in which clinical trials have 
been undertaken; they include the United Kingdom, United States, South Africa, Japan and 
Ireland (Figure 1.2 is adapted from https://www.copperalloystewardship.com/). However, 
similar clinical trials have not been performed in New Zealand. 
 
 
Figure 1.2. Worldwide hospital trials assessing the 
antimicrobial efficiency of copper alloys. This figure is adapted 
from the EPA Registration Copper Stewardship Site 
(https://www.copperalloystewardship.com/) 
 
Overall, the data so far consistently indicate that compared to the control materials such 
as glass, plastics and stainless steel, the introduction of copper-containing surfaces can 
decrease infection risk by around a quarter on a continuous basis (Pineda et al., 2017). 
The first ten-week clinical trial conducted at Selly Oak Hospital in Birmingham, UK, showed 
that bacterial contamination on copper-containing toilet seats, tap handles and door push 
plates was 90% to 100% lesser than when using other standard materials. More importantly, 
no methicillin sensitive Staphylococcus aureus (MSSA), VRE and E. coli were isolated from 
the copper surfaces (Casey et al., 2010). More recently, a large clinical trial took place in 
the Unites States in the ICUs over a period of 43 months. The result showed that the 
introduction of copper alloys resulted in a significant reduction (around 80%) of microbial 




Taken together, all these trials supported the efficacy of copper-based composite coating 
in reducing HAIs within hospital facilities and providing a safer environment for both 
patients and healthcare workers. 
 
1.3 The mechanism of metallic copper-induced cell death  
1.3.1 The current understanding of copper-mediated contact killing 
Elucidating the mechanisms of copper-mediated contact killing can strengthen our 
comprehension about the use of copper surfaces in healthcare settings and their further 
development. However, the chemical interactions of the bacterial-metal contact are quite 
complex, and consequently, the mechanisms underlying bacterial inactivation on copper 
surfaces are yet to be fully understood. 
 
At the current state of knowledge, it appears that copper-mediated contact killing initiates 
with dissolving of copper ions released from copper surfaces. Then, bacterial cells suffer a 
nonenzymatic oxidative damage of membrane phospholipids, leading to the leakage of 
specific nutrients. Following the damage of the outer and inner bacterial cell membrane, 
the released copper ions can penetrate the bacterial cell, thus facilitating the access of 
copper ions into cellular components. The increased amount of intracellular copper ions, 
in turn, causes irreversible oxidative stress and the production of hydroxyl radicals 
demonstrated by a redox cycling between the different forms of copper ions (Vincent et al., 
2017). 
 
Overall, although current evidence clearly indicates that the ROS damage induced by 
copper ions dissolved from metallic copper is the major cause of cell death during the 
contact killing process, the contact killing mediated by copper and its alloys is a combined 
effect and there are other mechanisms where the metal-bacterial contact damages the cell 
envelope. However, the exact sequential events of copper contact killing of cellular 
substances and their relative importance remain elusive and may in fact be different, 
depending on the type of microorganism (Warnes et al., 2012). 
 
1.3.2 The toxicity of copper ion 
Copper is a nutrient element essentially required for most prokaryotic and eukaryotic 
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organisms. The ionic form of copper is crucial for cell metabolism as it is required as a 
cofactor for many cellular enzymes such as cytochrome oxidase, superoxide dismutase 
and lysyl oxidase and electron transport proteins owing to its redox-active capacity to 
alternate between cuprous Cu+ (the reduction state) and cupric Cu2+ (the oxidation state). 
However, copper ion is toxic to bacterial cells when in surplus (Grass et al., 2010). Inside 
the bacterial cytoplasm, highly reactive hydroxyl radicals (ROS) are generated through the 
following Fenton-type reaction combined with the Haber-Weiss cycle (Liochev & Fridovich, 
2002): 
 
Cu+ + H2O2 = Cu2+ + 2OH- 
 
Copper ions can also cause the depletion of sulfhydryls, such as in cysteines or 
glutathiones, in a cycle between the following two reactions: 
 
2Cu2+ + 2RSH = 2Cu+ +RSSR +2H+ 
2Cu+ +2H+ + O2 = 2Cu2+ + H2O2 
 
Then, the hydrogen peroxide can participate in the abovementioned Fenton-type reaction 
and the Haber-Weiss cycle, amplifying the generation of toxic free hydroxyl radicals. Under 
aerobic conditions, those copper-induced extremely reactive hydroxyl radicals can 
efficiently induce pathology by inhibiting cellular respiration, causing irreversible oxidative 
damage of cellular molecules, such as lipids, proteins and deoxyribonucleic acid (DNA) 
(Espirito Santo et al., 2008). Cellular ROS stress and membrane lipid peroxidation induced 
by ionic copper have been observed in Escherichia coli and Salmonella cells when 
exposed to metallic copper alloys (Mathews et al., 2015). However, bacterial cells have 
evolved multiple mechanisms to maintain a low concentration of intracellular H2O2, thus 
preventing the damage caused by ROS. On the other hand, an alternative route of copper 
ion toxicity has been shown to cause non-Fenton damage in E. coli (Vincent et al., 2018). 
With the presence of copper ions, iron-sulfur cluster enzymes are inactivated as a result of 
the displacement of iron atoms from iron-sulfur clusters and a copper binding to the 
corresponding sulfur atom, resulting in the damage of several catabolic and biosynthetic 
pathways (Macomber & Imlay, 2009). Therefore, the toxicity of ionic copper is ascribable 
to the capacity of generating ROS by redox cycling between the different copper species 




However, copper is considered safe for regular contacts as a common metal with a long 
history of domestic use, as is evidenced by the recorded low possibility of adverse 
reactions (O’gorman & Humphreys, 2012). Previous research indicated that the 
concentration of free ionic copper released from the surface of metallic copper is only 
around 0.3 μM during 24h at 25 oC, which is not sufficient to kill pathogenic bacteria 
(Espirito Santo et al., 2008). In another research, Mathews et al. (2013) placed a synthetic 
inert polymer between copper coupons and Enterococcus hirae cells in order to prevent 
the direct contact between bacterial cells without affecting the transmission of the released 
copper ions. Surprisingly, the result showed that a rapid killing of bacteria was strongly 
attenuated: cell survival was reduced only by 1 log even after 3.5 h whereas more than 
106 bacteria cells were completely killed on uncoated copper coupons within 30 min. Thus, 




Figure 1.3. SEM image of the honeycomb-like structures of E. hirae cells. E. hirae cells 
were wet plated on a CA contact array and the sample was processed for electron 
microscopy after air drying. (A) Image at low magnification; (B) image at high magnification 
(Mathews, et al., 2013). 
 
Taken together, the information available suggests that the toxicity of copper ions can only 
partially explain the contact killing mediated by metallic copper. There are other 
mechanisms attributable to the observed rapid killing of bacterial cells upon contact with 
metallic copper in addition to the free radical-induced oxidative damage. 
 
1.3.3 The copper ions burst releasing hypothesis 
The current model of contact killing, as shown in Figure 1.4, was proposed by Grass et al. 
(2011). This model highlights the contribution of toxic copper ions to bacterial cell death, 





Figure 1.4. Current model of the tentative events in contact killing. (A) 
Copper dissolves from the copper surface and causes cell damage. (B) 
The cell membrane ruptures because of copper and other stress 
phenomena, leading to the loss of membrane potential and cytoplasmic 
content. (C) Copper ions induce the generation of reactive oxygen species, 
which cause further cell damage. (D) Genomic and plasmid DNA becomes 
degraded (Grass et al., 2011). 
 
All bacterial strains harbour several copper chelating factors and copper efflux systems 
that mainly serve to pump excess copper ions outside of cells and detoxify the copper ions 
from the cytoplasm or periplasm. However, these systems can only delay rather than 
prevent bacterial cell death upon contact with metallic copper, contradicting ion release 
from metallic copper surface as the lethal agent (Espírito Santo et al., 2008). Thus, it is 
reasonable to assume that when exposed to metallic copper, bacterial cells continuously 
absorb and accumulate large amounts of intracellular copper ions until the copper efflux 
systems are outpaced, thereby resulting in cell death. 
 
In general, bacterial cells produce various forms of extracellular components such as 
extracellular polymeric substances (EPS), lipopolysaccharide (LPS), capsule, pili and 
flagella, which contain nitrogen, sulphate or phosphate in their structure, providing bacteria 
from environmental stresses (Kleanthous & Armitage, 2015). These cell surface 
components normally contain nitrogen, sulphate or phosphate in their structure and 
potentially react with copper ions, thus producing more and more toxic copper ions. The 
EPS and polysaccharides isolated from EPS have been reported previously to be capable 
of binding heavy metals, in particular Cu (Mittelman & Geesey, 1985; Chen et al., 2011). 
These strongly indicate that the contact between metallic copper and bacterial surface 
components seems to be sufficient to trigger a release of copper ions from the surface. 
 
The recent work by Liu and Zhang (2016) showed that EPS and LPS stimulated the rates 
of copper-mediated contact killing, in agreement with the copper ions burst releasing 
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hypothesis that bacterial cells are predominantly killed by a burst release of toxic copper 
ions (Cu+/Cu2+) resulting from chemical interactions between bacterial cell surface 
components and copper surfaces (Figure 1.5). The copper ions burst releasing hypothesis 
clearly explains the accumulation of copper ions and highlights the critical role of copper 
ions in copper contact killing. 
 
 
Figure 1.5. The copper ion burst releasing (CIBR) model of 
contact killing. Cell surface components, such as 
exopolysaccharides (EPS), lipopolysaccharide (LPS), pili and 
flagella, can react with copper ions and are critical in copper-
mediated contact killing (Liu & Zhang, 2016). 
 
1.4 The potential of bacteria to develop overlapping resistance to copper 
and antibiotics 
1.4.1 The mechanism and medical use of antibiotics 
Antibiotics refer to the antibacterial substances that act by inhibiting the growth of bacteria 
and directly killing bacteria or through a combination of both mechanisms. Since the 
discovery of the antibiotic penicillin by Sir Alexander Fleming in 1928, antibiotic 
medications have been widely used in hospitals to treat or prevent bacterial infections 
(Ventola, 2015). In this study, we chose nine types of antibiotics covering major classes 
and measured their minimal inhibitory concentration of evolved strains. Several of them 
are on the World Health Organization’s List of Essential Medicines, which contains the 
most effective medicines in the health system. 
 
The aminoglycosides are one of the oldest classes of antimicrobial agents derived from 
Streptomyces or Micromonospora spp and include kanamycin, tobramycin, neomycin, 
gentamicin and streptomycin. After the aminoglycosides enter the bacterial cells through 
the outer cell membrane, the aminoglycosides exert their antibacterial activity by binding 
to the aminoacyl site of 16S ribosomal RNA (rRNA) within the 30S ribosomal subunit 
(Farouk et al., 2015). Aminoglycosides exhibit antimicrobial activity against a wide 
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spectrum of different microorganisms and were frequently prescribed to treat complicated 
urinary tract infections in clinical practice. Additionally, despite being presented with the 
significant problem of advancing antimicrobial resistance, aminoglycosides are still widely 
used in everyday practice in combination with other antibiotic agents in spite of its potential 
for renal toxicity and ototoxicity (Spelman et al., 1989). 
 
Beta-lactam antibiotics, such as ampicillin and carbenicillin, are the most frequently used 
antibiotics worldwide and constitute the basis of antimicrobial treatment of infections 
caused by susceptible organisms. Most beta-lactam antibiotics prevent bacterial growth by 
inhibiting the synthesis of a peptidoglycan layer of bacterial cell walls (Fisher et al., 2008). 
Until 2003, β-lactam compounds accounted for more than half of the commercially 
available antibiotics for medical use (Elander, 2003). 
 
Tetracycline displays a low toxicity and broad spectrum against both gram-negative and 
gram-positive bacteria. Tetracycline inhibits protein synthesis by preventing the attachment 
of aminoacyl-tRNA to the 30S subunit of ribosomal acceptor (A) site, thus causing bacterial 
cell death (Chopra & Roberts, 2001). As it can be taken orally and is inexpensive, due to 
its the absence of reported adverse side effects, tetracycline was extensively used in the 
United States during the 1950s and was particularly prescribed for outpatient therapy 
(Speer et al., 1992). Although, nowadays, the emergence of tetracycline-resistant strains 
limits the use of tetracycline, tetracycline is still used to treat gastritis and the peptic ulcer 
disease associated with Helicobacter pylori (Chopra & Roberts, 2001). 
 
Nalidixic acid belonging to the fluoroquinolones antibiotics possesses a broad spectrum of 
antimicrobial activity. Following a simple diffusion across the bacterial cell membrane, 
nalidixic acid acts in a bactericidal manner by binding to the DNA gyrase and DNA 
topoisomerase IV essential for mediating the topological state of DNA (Zhanel et al., 2002). 
However, the medical use of nalidixic acid is limited to the oral treatment of urinary tract 
infections (Blondeau, 1999). 
 
1.4.2 The antibiotic resistance crisis 
Antibiotics are considered among the major breakthroughs in modern medicine for making 
a significant contribution to health care-associated bacterial infections. However, according 
to the World Health Organization, the emergence and dissemination of antibiotic resistance 
and multi-drug resistance subsequent to antibiotic use are recognised as a major global 
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threat to public health and may become the leading cause of death by 2050 (O’Neill et al., 
2016). For example, MRSA is the cause of deaths of nearly 20,000 people and more than 
300,000 hospitalisations in the United States annually (Martens & Demain, 2017). Antibiotic 
resistance is also considered a huge economic burden to health care and society at large. 
Although there is an absence of data on the economic burden of antibiotic resistance in 
New Zealand, it is estimated that antibiotic resistance costs the U.S. health care system 
$20 billion (Nguyen et al., 2019). Following globalisation, antibiotic resistance may become 
more serious. 
 
Bacteria can intrinsically be resistant to certain classes of antibiotics. The molecular basis 
of the intrinsic resistance of Gram-negative bacteria to Gram-positive antibiotics is the 
presence of the Gram-negative outer membrane impermeable to many antibiotics such as 
vancomycin and active efflux pumps serving to reduce the intracellular concentration of 
antibiotics (Cox & Wright, 2013). 
 
In addition to the intrinsic resistance of bacterial pathogens, bacteria can evolve inheritable 
resistance to antibiotics through direct acquisition of new antibiotic-resistant genes via 
mobile genetic elements or the modification of existing genes under an environmental 
selection caused by antibiotics or other antimicrobials. Genetic mechanisms underlying an 
evolved antibiotic resistance include modification of the intracellular target through genetic 
mutation or post-translational modification to decrease the binding capacity of antibiotics, 
over-expression of efflux systems and decreased expression of antibiotic uptake system, 
mutations regarding biofilm formation and drug inactivation by enzymes such as β-
lactamase (Tegos et al., 2012). For instance, the MRSA phenotype results from the 
mutation of penicillin-binding proteins (PBPs) with low-affinity to β-lactam antibiotics, 
encoded by the horizontally acquired mecA genes on its chromosomal DNA, that take over 
the functions of the resident staphylococcal PBPs and hence confers resistance to 




Figure 1.6. Trends of total antimicrobial resistance by common antibiotics. 
A retrospective record review of data was collected from the microbiology 
department at a private laboratory between January 2012 and December 2017. 
(Mhondoro et al., 2019). 
 
1.4.3 The mechanism of co-selection of heavy metals and antibiotics  
While inappropriate prescription and the large-scale production of antibiotics in medicine 
and agriculture clearly stimulates the proliferation of antibiotic resistance, heavy metals 
have also been suggested to play an important role. The anthropogenic application of 
antibacterial metal (ion) in the environment coupled with their persistence allows for long-
term impacts and interactions with microbial communities and the subsequent selection for 
metal resistance and indirect co-selection for antibiotic resistance, facilitating intra- and 
interspecies spread. The structural and functional characteristics of antibiotic resistance 
share common strategies with those with heavy metal resistance. When a mutation confers 
to resistance to both metals and antibiotics (cross-resistance) or when metal resistance- 
and antibiotic resistance-genes are genetically linked to mobile genetic elements (co-
resistance), metals can co-select for resistance to clinically relevant antibiotics (Baker-
Austin et al., 2006). 
 
There is a concern often voiced about the emergence of pathogens resistant to metallic 
copper as a result of the increased and constant use of antimicrobial copper alloys in the 
healthcare setting, similar to the spread of antibiotic-resistant microbes after the 
introduction of antibiotics. In a worst-case scenario, the impacts of metallic copper on the 
current medical use of common antibiotics might become an issue, as copper functions as 
a long-lasting selective agent. Copper and copper-containing compounds have been 
extensively used in agriculture and aquaculture for centuries as bactericides and fungicides. 
Previous research has shown that copper amendment in soil environments selects for 
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various antibiotic resistance in the copper resistant bacteria (Berg et al., 2005; Seiler & 
Berendonk, 2012). In terms of molecular mechanisms, taking E. coli as an example, it has 
been revealed that copper defence was metabolically associated with antibiotic resistance 
through a conserved multiple antibiotic resistance regulator (MarR) family of transcription 
factors (Hao et al., 2014). 
 
Therefore, it is highly possible that bacteria resistant to copper may exhibit reduced 
susceptibility to antibiotics and antiseptics due to the increased use of metallic copper 
surfaces in healthcare settings. However, this has rarely been experimented. Until now, 
there has been only one research testing the antibiotic resistance of bacteria surviving on 
copper coins (Espirito Santo et al., 2010). Although the result indicated that coin bacteria 
were no more antibiotic resistant than their type strains, it cannot be concluded that copper 
resistance is not linked to antibiotic resistance as these bacteria were also sensitive to 
copper surfaces. 
 
1.5 The mechanism of copper homeostasis in bacteria 
The majority of bacteria require trace quantities of copper for basic cellular function such 
as oxidative phosphorylation and photosynthesis, whereas copper ions are highly toxic to 
bacterial cells when in excess. It is therefore critical for micro-organisms to evolve into a 
network of well-regulated copper homeostasis systems in order to balance the cellular 
requirement for copper with the adversary effects of overexposure to copper ions. So far, 
the mechanisms of copper homeostasis generally include efficient extracellular uptake of 
copper ions, intracellular copper-specific transport, relative impermeability of the outer and 
inner bacterial membranes to copper ions, metallothionein-like copper-scavenging proteins 
in the periplasm and active export of copper from cells in the extracellular environment 
through copper-ATPase export pumps (Zhang & Rainey, 2008; Grass et al., 2011).  
 
For example, the non-pathogenic SBW25, which is the model organism of Pseudomonas 
fluorescens, is a plasmid-free plant growth-promoting bacterium that was originally isolated 
from the phyllosphere of field-grown sugar beet (Bailey et al., 1995). Due to its plant growth 
promoting properties and potential as a biocontrol agent, SBW25 has been extensively 
studied and the genome of SBW25 has been sequenced. As it can evolve rapidly when 
exposed to the appropriate selection pressure to generate a large repertoire of mutants, 
SBW25 is extensively used in many experimental evolution studies (Rainey & Travisano, 
1998; Trippe et al., 2013). In SBW25, two copper-specific transporter systems (Cop and 
26 
 
Cue) are integrally responsible for copper homeostasis and the expression of both is 
regulated by concentration of copper ions in the medium (Figure 1.7). In environment 
replete with copper, the Cue systems involving CueA and CueZ are up-expressed to 
transport excess copper ions outside the bacterial cells under control of the MerR-type 
CueR regulator, thereby maintaining intracellular copper levels at subtoxic levels and 
minimising deleterious effects. Under low copper concentrations, the Cop system involving 
CopCD is activated under the control of CopRS to facilitate the cellular copper uptake, 




Figure 1.7. A proposed model of copper homeostasis in P. 
fluorescens SBW25. Expression of the gene copCD is controlled by 
CopRS. The system is activated at low levels of copper and repressed 
by high concentration of copper. Together the Cue system serves to 
pump excess copper ions out of the bacterial cell. Expression of cueA 
and cueZ is controlled by CueR. Both CopRS and CueR are subject 
to self-regulation (Zhang & Rainey, 2008). 
 
P. aeruginosa, which belongs to the same genus as the P. fluorescens, is a gram-negative 
rod-shaped bacterium mainly thriving in moist environments, such as water and soil (Bodey 
et al., 1983). P. aeruginosa is of medical importance as it has recently emerged as an 
opportunistic nosocomial respiratory pathogen responsible for a wide range of HAIs in most 
long-term care facilities during the past two decades. Of high clinical relevance is the ability 
of P. aeruginosa to establish itself within the lungs of those with cystic fibrosis (CF, a genetic 
disorder caused by a mutation in cftr gene). PAO1 is the archetypal strain of P. aeruginosa 
and has undergone complete genome sequencing (Wright et al., 2019).  
 
In P. aeruginosa PAO1, the major components of copper homeostasis can be described in 
the form of three systems: CueR-controlled genes that maintain cytoplasmic Cu+ levels, 
mainly involving a plasma membrane CopA1 and a CusCAB transport system; genes 
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under control of the Cu2+-sensing two-component CopR/S system regulating Cu+ 
periplasmic distribution; along with genes probably involved in copper influx strongly down-
regulated in the presence of external Cu2+ (Figure 1.8. Quintana et al., 2017). 
 
 
Figure 1.8. A proposed model of copper homeostasis in P. aeruginosa PAO1. The model 
depicts key components of P. aeruginosa copper ion distribution mechanisms. The candidates for 
Cu+ influx transporters (green, down-regulated genes), the CopR and CueR regulon (red, up-
regulated genes), and the proteins responsible for metallation of cuproproteins (non-induced) are 
shown. Blue, transmembrane transporters; orange, transcriptional regulators; green, 
cuproproteins; yellow, chaperones; gray, proteins of unknown role. Hexagonal shapes highlight 
redox activity (Quintana et al., 2017). 
 
In this study, we used an evolutionary experiment based on the selection of random 
mutants accumulated in the MPAO1 and SBW25 population either spontaneously or upon 
mutagenesis to explore the potential of bacteria to develop resistance to ionic copper and 
better understand the biological response of bacterial cells to copper exposure. 
 
1.6 Specific objectives of this study 
The primary goal of this project is to assess the risk of introducing copper alloys in hospital 
environment. More specifically, we tested a hypothesis that bacterial pathogens can 
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develop resistance to metallic copper and ionic copper, which is overlapped with resistance 
to antibiotics. To test this hypothesis, we conducted evolution experiments on metallic 
copper and to copper ions. 
 
Specific aims of this project are listed as below. 
 
1. Experimental evolution of bacterial resistance to metallic copper.  
o A non-pathogenic strain of P. fluorescens SBW25 was subjected to a daily passage of 
sub-lethal conditions on the surface of brass (Cu 63.5%) and pure copper. Rates of 
copper contact killing will be determined every 10 days for a period of 320 days in total. 
The accumulated mutations were determined by re-sequencing the genomes of the 
evolved strains. 
 
Of note, this experimental task was performed by previous researchers in Zhang’s lab. 
 
o Phenotypic characterization of functional traits associated with the evolution of 
copper resistance. The evolved P. fluorescens strains were subjected to phenotypic 
analysis of mutation rate (a), their ability of pyoverdine production (b), minimum 
inhibitory concentrations of copper ions (c). 
 
o Investigation of the probable overlapping antimicrobial resistance to metallic 
copper and antibiotics and antiseptics This work was performed by comparing 
bacterial resistance to various classes of antibiotics with a non-pathogenic model 
strain of Pseudomonas fluorescens SBW25 and evolved strains subjected to long-
term copper contact killing, also involving a panel of mutants derived from SBW25.  
 
2. Experimental evolution of bacterial resistance to ionic copper.  
This work was performed using a non-pathogenic strain of P. fluorescens SBW25 and 
a pathogenic strain of P. aeruginosa MPAO1. The two bacterial species were 
subjected to  
o Broth-to-broth transfer in LB broth supplemented with CuSO4 at sub-lethal 
concentrations. 





This work is still on-going in Zhang’s lab, but the levels of bacterial resistance to copper 





CHAPTER TWO: MATERIALS AND METHODS 
 
2.1 Bacterial strains and growth conditions 
Major bacterial strains and plasmids used in this study are provided in Table 2.1. These 
strains from the -80 oC freezer were routinely inoculated into Luria Bertani (LB) broth, also 
referred to as lysogeny broth, which is a nutritionally rich medium. P. aeruginosa strains 
were grown at 37 oC while P. fluorescens strains were grown at 28 oC (Sambrook et al. 
1989). P. fluorescens strains were also grown in minimal M9 minimal medium 
supplemented with histidine and succinate as the nitrogen and carbon sources, at the final 
concentration of 10 and 20 mM, respectively. Where appropriate, the following antibiotics 
and other supplements were also added to the growth media at the indicated 
concentrations except where specifically indicated: X-Gal (40 μg/ml), gentamicin (Gem), 
kanamycin (Km), tobramycin (Tb), nalidixic acid (Nal, 75 μg/ml), ampicillin (Amp), 
carbenicillin (Cb), neomycin (Nm), penicillin (Pen), streptomycin (Str), tetracycline (Te). 
 
Table 2.1. List of bacterial strains and plasmids used in this study 
Strains or 
plasmids 
Genotypes and relevant characteristics Source/reference 
P. fluorescens   
SBW25 Wild type strain isolated from phyllosphere of a 
sugar beet plant grown at the University of 
Oxford farm 
Bailey et al. 1995 
MU30-5 Δ mutS, an allelic exchange mutS deletion 
mutant of P. fluorescens SBW25 
X.-X. Zhang, 
unpublished 
MU30-11 ΔmutL, an allelic exchange mutL deletion mutant 
of P. fluorescens SBW25 
X.-X. Zhang, 
unpublished 
MU6-16 ΔcueA, a SBW25-derived strain with a nonpolar 
cueA deletion 
X.-X. Zhang and 
P. B. Rainey, 2007 
SBW25-lacZ SBW25 harboring a neutral, chromosomal lacZ 
marker in a phage locus 
X.-X. Zhang and 
P. B. Rainey 
MU6-61 ΔpvdL, SBW25 mutant with a deletion of pvdL 
defective in production of pyoverdine 
Moon et al. 2008 





C2 control group replicate 2 of the 320th evolution 
experiment transfer 
unpublished 
C3 control group replicate 3 of the 320th evolution 
experiment transfer 
unpublished 
C4 control group replicate 4 of the 320th evolution 
experiment transfer 
unpublished 
C5 control group replicate 5 of the 320th evolution 
experiment transfer 
unpublished 
C6 control group replicate 6 of the 320th evolution 
experiment transfer 
unpublished 
C7 control group replicate 7 of the 320th evolution 
experiment transfer 
unpublished 
C8 control group replicate 8 of the 320th evolution 
experiment transfer 
unpublished 
D1 replicate 1 subjected to metallic copper contact-
killing of the 320th transfer 
unpublished 
D2 replicate 2 subjected to metallic copper contact-
killing of the 320th transfer 
unpublished 
D3 replicate 3 subjected to metallic copper contact-
killing of the 320th transfer 
unpublished 
D4 replicate 4 subjected to metallic copper contact-
killing of the 320th transfer 
unpublished 
D5 replicate 5 subjected to metallic copper contact-
killing of the 320th transfer 
unpublished 
D6 replicate 6 subjected to metallic copper contact-
killing of the 320th transfer 
unpublished 
D7 replicate 7 subjected to metallic copper contact-
killing of the 320th transfer 
unpublished 
D8 replicate 8 subjected to metallic copper contact-
killing of the 320th transfer 
unpublished 
P. aeruginosa   
MPAO1 Wild type strain obtained from B. Iglewski 
(Department of Microbiology, University of 
Rochester Medical Center, Rochester, NY) 
Jacobs et al., 
2003 
Plasmids   
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pUX-BF13 Helper plasmid for transposition of mini-Tn7 
element, Apr 
Bao et al., 1991 
PhutuJ-mini- 
Tn7T-Gm-lacZ 




















Mini-Tn7 vector, Apr, Gmr Naren, 
unpublished 
 
2.2 Laboratory media 
LB medium, KB medium and minimal M9 salt medium were prepared according to the 
preparation protocols listed in Table 2.2. They were sterilized by autoclaving at 121 oC for 
20 minutes. When preparing KB medium, 1.5 g/l sterile magnesium sulphate (MgSO4) was 
added after autoclaving all other medium components to avoid precipitation. For the 
preparation of M9 medium, magnesium sulfate (MgSO4) stock solution was filter-sterilized 
and stored at 4 oC. Base M9 minimal salts were of standard composition. When P. 
fluorescens was grown in the minimal M9 salt medium (Sambrook et al., 1989), carbon 
source (succinate) and nitrogen source (histidine) was supplemented at the final 
concentration of 20 mM and 10 mM, respectively, except where indicated. Medium 
supplements such as copper sulfate and X-Gal solution were sterilized by syringe filters 
and then added after autoclaved LB agar had been cooled to around 50 oC at a water bash. 
 
Bacterial strains were stored in glycerol-saline solution at -80 oC to remain structurally 
viable. Glycerol-saline stock in a 2 ml plastic screw top tube was prepared by mixing 1000 
μl of the bacterial culture with 800 μl of the 70% glycerol solution which contains 8.5 g 





Table 2.2. List of laboratory media used in this study 
LB medium  Application 
Tryptone (10 g/l) 
Yeast Extract (5 g/l) 
Sodium Chloride (10 g/l) 
Agar (15 g/l) Agar plates 
X-Gal (40 μg/ml) Identification of strains with 
lacZ marker 
KB medium   
Glycerol (10 g/ml) 
Proteose Peptone (10 g/l) 
Dipotassium Hydrogen Phosphate 
(1.5 g/l) 
Magnesium Sulphate. Heptahydrate 
(1.5 g/l) 
  
Minimal M9 salt medium   
M9 minimal salts (5 X) 
Magnesium sulfate (1 M) 
Histidine (10 mM) 
Succinate (20 mM) 
  
 
2.3 Bacterial susceptibility to copper sulfate in P. fluorescens 
The minimal inhibitory concentration (MIC) of copper sulfate was determined on LB agar 
plates containing varying concentrations of CuSO4. Two replicates were performed for 
each concentration to measure the most accurate MIC possible. The stock solution of 100 
mM CuSO4 was prepared by dissolving 1.25 g of pentahydrate CuSO4 into 100 ml of sterile 
water and CuSO4 stock solution was sterilized through a 0.22 µm syringe filter (Millipore) 
and stored at room temperature (around 20 oC). 20 ml LB agar was added into a petri dish 
supplemented with an appropriate amount of 100 mM CuSO4 solution. Before use, agar 
plates were left at room temperature (around 20 oC) for more than 24 hours to let plates 
solidify and dry. 
 
For inoculum preparation, 0.5 ml of the overnight bacterial culture of each strain was spun 
down for one minute. The supernatant of each tube was removed and each cell pellet was 
re-suspended with the same amount of sterile water. After making a 10-time dilution by 
adding 100 μl of the resuspension bacterial culture into 900 μl sterile water, 10 μl of the 
dilution was dropped onto the surface of LB agar plates containing different concentrations 
of CuSO4. The bacterial growth was examined and photographed at 24, 48 and 72 hours 
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after inoculation at 28 oC. In this study, MIC was defined as the minimum concentration of 
copper at which no visible bacterial growth was observed after 48 or 72-hour incubation. 
 
2.4 Determining the minimal inhibitory concentration of antibiotics in P. 
fluorescens 
The antibiotics used in this study were ampicillin (Thermo Fisher), carbenicillin (Sigma-
Aldrich), penicillin (Thermo Fisher), gentamicin (Melford), kanamycin (Thermo Fisher), 
nalidixic acid (Sigma-Aldrich), neomycin (Fisher Bioreagents), streptomycin (Melford), 
tetracycline (Thermo Fisher) and tobramycin (Sigma-Aldrich). Recipes of antibiotic stock 
solution are shown in Table 2.3. After solubilizing the antibiotic powder, antibiotic stock 
solution was sterilized by membrane filtration and stored in 20 ml sterile vials in -20 oC 
freezer. When preparing agar plates, 20 ml LB agar was added with each plate containing 
the following final concentrations of antibiotics: 128, 64, 32, 16, 8, 4, 2, 1, 0.5, 0.25, 0.06, 
0 µg/ml.  
 
Table 2.3. List of antibiotics used in this study 
Antibiotic Stock concentration  
Ampicillin 50 mg/ml add 500 mg into 10 ml sterile water 
Carbenicillin 50 mg/ml add 500 mg into 10 ml sterile water 
Penicillin 50 mg/ml add 500 mg into 10 ml sterile water 
Gentamicin 10 mg/ml add 100mg into 10ml sterile water 
Kanamycin 50 mg/ml add 500 mg into 10 ml sterile water 
Nalidixic acid 20 mg/ml add 500 mg into 10 ml sterile water 
Neomycin 50 mg/ml add 500 mg into 10 ml sterile water 
Streptomycin 10 mg/ml add 100mg into 10ml sterile water 
Tetracycline 10 mg/ml add 100 mg into 10 ml 70% ethanol 
Tobramycin 10 mg/ml add 30 mg into 3 ml sterile water 
 
To prepare the bacterial inoculants, strains stored in -80 oC freezer were inoculated into 5 
ml LB broth and incubated at 28 oC in a shaker until they achieve a full growth before used 
in assay conditions. After about 20 hours, the overnight culture was subjected to a diluted 
a 100-fold dilution by adding 10 μl culture to 990 μl sterile water, resulting in a bacterial 
suspension with 1x106 cfu ml-1. After dilution, 10 μl of the cell solutions was inoculated onto 
agar plates supplemented with antibiotics, such that one drop contained around 104 cells. 
Two replicates were performed for each concentration. Colony growth was recorded and 
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photographed daily during the incubation for a period of 3 days at 28 oC. 
 
2.5 Measurement of growth kinetics in M9 minimal medium and LB 
medium supplemented with tobramycin 
To ensure strains in growth curve comparisons were physiologically equal, wild type P. 
fluorescens SBW25, evolved copper treatment strains and evolved control strains were 
inoculated directly from bacterial stocks that had been stored at 80 ºC, grown in 5 ml LB 
broth at 28 ºC overnight and then re-grown in M9 broth or LB broth. When grown in LB 
medium, a 200 μl aliquot of each bacterial culture with varying concentrations of tobramycin 
was directly added into a 96-well microplate (3 replicates). When grown in M9 minimal 
medium supplanted with succinate (20 mM) as carbon source and histidine (10 mM) as 
nitrogen source, 1 ml of the overnight bacterial culture was pelleted and washed with M9 
salts (1:100 dilution to 1 X) twice. A 200 μl aliquot of each bacterial culture with varying 
concentrations of tobramycin was added into a well of a 96-well microplate (3 replicates). 
Growth kinetics of SBW25 and evolved strains were monitored at 28 ºC using a Synergy™ 
2 multi-mode plate reader equipped with Gen5 software (Bio-Tek). Absorbance at 450 nm 
was measured at 5 minutes intervals for a period of 24 hours when grown in LB medium 
or 48 hours in M9 minimal medium. The plate was shaken for 10 seconds prior to each 
read. 
 
2.6 Assay for bacterial fitness 
Relative fitness of evolved strains was determined by direct competition. Cells were 
prepared from cultures stored at −80 ◦C, first grown in 5 ml LB broth at 28 ◦C overnight. To 
initiate the competition, the wild type SBW25 strain used as the competitor was mixed 1:1 
with the evolved strain and 5 μl of the mixed culture was inoculated into 5 ml fresh LB 
medium (each with four replicates). To count the starting ratio, mixed bacteria was subject 
to serial 106 and 107-fold dilution in sterile water and 100 μl of each dilution was inoculated 
onto LB plus X-Gal plates. After 24-hour incubation at 28 ◦C, the 10-6 and 10-7 dilutions of 
mixed bacteria were placed out onto LB plus X-Gal plates to count the end ratio. Two days 
after inoculation, colonies each plate were counted. Relative fitness was calculated as log 
ratio of Malthusian parameters of the two strains being compared (Lenski et al. 1991). 
 
When measuring bacterial fitness in tobramycin, 5 μl of the mixed culture was inoculated 
into 5 ml LB medium supplemented with 2 μg/ml tobramycin and mixed bacteria was 
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subject to serial 104, 105 and 106-fold dilution in sterile water before being placed out. 
 
2.7 Pyoverdine production measurement 
To estimate the production of pyoverdine, the experimental culture was prepared by 
transferring 5 μl overnight culture of LB broth to 5 ml LB broth and KB broth, respectively. 
Four biological replicates were performed for each broth per strain culture. Following 24-
hour and 48-hour incubation at 28 oC, the supernatant was transferred to a 96-well 
microtiter plate. In this step, four technical replicates were performed to minimize 
experimental errors. Pyoverdine production was measured in relative fluorescence units 
(RFU) by measuring fluorescence at the excitation wavelength of 360 nm and the emission 
wavelength of 460 nm using a Synergy™ 2 plate reader equipped with Gen5 software, with 
the mean pyoverdine production calculated. The respective broth media was used as the 
blank. Simultaneously, cell density was assayed in the absorbance at the wavelength of 
600 nm (A600).  
 
2.8 Measurement of bacterial mutation rate 
Mutation rate was measured using a so-called Luria-Delbrück fluctuation assay. In this 
study, the fluctuation assay was performed on single colonies from evolved strains of 
previous experimental evolution and wild type SBW25 strain. Evolved strains and wild type 
SBW25 strain stored in glycerol-saline at -80 ºC were streaked onto LB agar plates and 
grown at 28 oC for single colonies. After two-day incubation, a single colony picked up from 
the plate and inoculated into 5 ml of LB broth and grown for 24 hours at 28 oC with orbital 
shaking. Assuming the cell density of an overnight bacterial culture of LB broth is around 
1x109 cells/ml, the fluctuation test was set up by inoculating of the dilution containing 
around 500 cells into a 25 ml tube containing 6 ml LB broth. After 24-hour incubation with 
orbital shaking at 28 oC to stationary phase, the frequency of nalidixic acid mutants was 
measured. To measure the number of nalidixic acid resistance colonies, the overnight 
bacterial culture was subjected to 100, 10-1 and 10-2 dilution and 100 μl of each dilution was 
placed out onto LB agar plates supplemented with 75 μg/ml nalidixic acid. To measure the 
total number of colonies, serial dilution of 10-5, 10-6 and 10-7 was performed on the 
overnight culture and 20 μl of each dilution was dropped onto the surface of the non-
selective LB agar plates using drop count method (3 replicates). 
 
Until colonies grew, the number of mutants resistant to nalidixic acid and total colonies per 
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plate were counted and the means were used in mutation rate calculations. The mutation 
rate was calculated online using an integrated web tool named as bz-rates (accessible at 
http://www.lcqb.upmc.fr/bzrates) which is based on Luria–Delbrück distribution-generating 
algorithm (Gillet-Markowska et al., 2015). 
 
2.9 Electroporation technique  
2.9.1 Preparation of electrocompetent Pseudomonas aeruginosa cells 
Prior to electroporation, MPAO1 strain stored in glycerol saline in -80 oC freezer was 
inoculated into 6 ml of LB broth medium and grown with orbital shaking overnight at 37 oC. 
1.5 ml of the overnight bacterial culture was centrifuged at 16 g for 2 minutes at room 
temperature (around 20 oC). After removing the supernatant, the pellet was further washed 
with 1 ml of 300 mM sterile sucrose stock solution twice. Bacterial cells were resuspended 
in 100 μl of 300 mM sucrose solution and were ready for electroporation. 
 
2.9.2 Transformation of Pseudomonas aeruginosa by electroporation 
DNAs of the desired plasmid (5 μl, ~100 ng) and the pUX-BF13 helper plasmid (5 μl, ~100 
ng) were added to 100 μl of electrocompetent cells (Bao, et al., 1991). After chilling on ice 
for 30 minutes, the bacterial and plasmid suspension was transferred and placed between 
electrodes of a pre-chilled 0.1 cm-gap Gene Pulser® electroporation cuvette (Bio-Rad) and 
electroporated using Electroporator 2510 (Eppendorf) at the following settings: 25 mF, 200 
Ohms, 1.8 kV.  
 
After transformation by electroporation, 600 μl of LB broth was immediately added into the 
1 mm cuvette. Then, all the bacterial culture was transferred from the cuvette into a 1.5 ml 
sterile eppendorf tube and incubated for 1 hour at 37 oC with orbital shaking. After being 
centrifuged and resuspended in 300 μl of LB broth, 150 μl of the bacterial culture was 
placed out onto LB plus X-Gal plates containing 30 μg/ml gentamicin and incubated at 37 
oC overnight. Until colonies grew, single colonies were picked up and inoculated into 5 ml 
LB broth with shaking overnight for long-term storage.  
 
To check whether the mini-Tn7 element system had been successfully integrated into the 
genome of MPAO1, a 170 bp fragment was amplified by PCR reaction (described in 
Method 2.11) using a pair of strain-specific primers MLG048-PF and MLGO49-PR. Then 
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strains were stored in glycerol-saline in -80 oC freezer and used as ancestral strains in 
experimental evolution of bacterial resistance to copper sulfate. 
 
2.10 Experimental evolution of bacterial resistance to ionic copper for 
Pseudomonas aeruginosa and Pseudomonas fluorescens 
This experimental evolution work was performed using P. fluorescens strain SBW25 and 
P. aeruginosa strain MPAO1 marked with lacZ. SBW25 is a model bacterium of P. 
fluorescens normally used in the experimental evolution study and P. aeruginosa MPAO1 
is a pathogenic micro-organism responsible for a wide range of HAIs.  
 
To check potential cross contamination using PCR reaction, each ancestral strain was 
inserted the lacZ marker with a unique promoter in the genome by electroporation 
described in Method 2.9. All these strains were marked with the lacZ gene encoding the 
protein beta-galactosidase, and thus colonies formed by strains with lacZ marker would 
show blue color on LB agar plates in the presence of X-Gal (40 μg/ml), ensuring no 
extraneous contamination and allowing the rapid identification of the evolved bacterial 
strains. 
 
In this work, we conducted both broth-to-broth transfer and colony-to-colony transfer to 
select for mutants with increased resistance to copper ions.  
 
2.10.1 Broth-to-broth transfer in LB broth 
As outlined in Figure 3.12 (see Results), we set up six independent cell lines for evolution 
experiment, with each carrying a lacz marker with a unique promoter in the genome. To 
ensure the sequestration between copper and the thiol-containing of LB broth (Nies and 
Herzberg, 2013), 5 ml LB broth supplemented with appropriate amount of 100 mM CuSO4 
were prepared in advance and subjected to orbital shaking for two hours before transfer. 5 
μl of the overnight culture of each line, prepared from the ancestral strain stored in -80 oC 
freezer, was then transferred to a 30 ml plastic tube containing 5 ml LB broth supplemented 
with subinhibitory concentration of CuSO4. As a control, six evolutionary lines of SBW25 
strains were transferred into 5 ml LB broth but without copper sulfate.  
 
During the process of broth-to-broth transfer, evolved bacterial strains were examined 
every ten transfers. First, bacterial culture was streaked onto LB plus X-Gal plates to check 
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if there is any possible extraneous microbial contamination. Secondly, to examine whether 
cross contamination between different lines occurred, identity of the P. fluorescens strains 
were confirmed by polymerase chain reaction (PCR), with each strain using six pairs of 
primers. Forward primers and reverse primers used as the reagent of PCR reaction are 
shown in Table 2.4 with the respective fragment length. Thirdly, bacterial cultures were 
streaked out onto LB plus X-gal plates supplanted with 30 μg/ml gentamicin to further verify 
the strain identity. 
 
After being verified by both streak plate method and PCR, strains were permanently stored 
in glycerol saline in -80 oC freezer for further whole genome sequencing to identify the 
mutations conferring copper resistance and phenotypic analysis.  
 
2.10.2 Colony-to-colony transfer on gradient LB agar plates 
2.10.2.1 Preparation of gradient LB agar plates supplemented with copper sulfate 
Colony-to-colony transfer was conducted by using linear gradient plates supplanted with 
sub-inhibitory concentration of copper sulfate. For the preparation of a linear gradient plate, 
two layers of LB agar were poured into each plate. 10 ml LB medium with 1.5% agar was 
added when the Petri plate was elevated. In this way, bottom layer formed a triangular 
wedge and the entire bottom was covered. The tilt direction was marked with an arrow. 
After 10 minutes to ensure the bottom layer completely harden, another 10 ml melted LB 
agar (around 60 oC) with appropriate amount of 100 mM CuSO4 solution was poured on 
the top of the bottom layer with the plate in the horizonal position. Linear gradient plates 
were prepared one day before applying spread plate technique, such that copper sulfate 
in the top layer diffused vertically and the surface of agar plates contained gradually varying 





Figure 2.1. Gradient LB agar plate consisting of two agar layers. 
Figure A shows the gradient plate, with the top layer supplemented with 
sub-inhibitory concentration of CuSO4 solution and bottom layer of plain 
LB agar. Figure B is a representative photo of gradient agar inoculated 
with SBW25 and the mutant colony was circled. 
 
2.10.2.2 Serial passages on gradient LB agar plates 
As outlined in Figure 3.15 (see Results), similar to broth-to-broth transfer, we set up six 
independent cell lines for evolution experiment, with each carrying a lacz marker with a 
unique promoter in the genome. 24 hours after the preparation of gradient LB agar plates, 
100 μl overnight culture of copper sulfate free LB broth of each line was placed evenly out 
onto gradient plates. SBW25 and MPAO1 was incubated at 28 ºC and 37 ºC, respectively. 
Until mutant grew, a single mutant near to the inhibition zone (cultured with subMICs) was 
picked up from the gradient plate and then streaked out onto a LB plus X-Gal plate for 
purification. After incubation for one or two days at 28 ºC or 37 ºC, a single colony showing 
blue color on LB plus X-Gal plate was inoculated into 5 ml LB broth and grown overnight 
for the next round of colony-to-colony transfer.  
 
During the process of colony-to-colony transfer, the mutant strain of each line after each 
cycle was stored in glycerol-saline at -80 ºC freezer and the information of each line was 







Table 2.4. List of forward primers and reverse primers 
 Forward Primer Reverse Primer Fragment length 
PhutuJ  PhutuJ lacz7 790 bp 
PhutF PhutF-F lacz7 705 bp 
PntrB  PntrB-1 lacz7 586 bp 
PcbrA cbrA-FB lacz7 1170 bp 
PcbrB cbrB-FB lacz7 1030 bp 
PplC plc-R lacz7 770 bp 
 
Table 2.5. Sequence of primers used in this study 











2.11 Standard PCR and agarose gel electrophoresis 
The reagents of PCR reaction are listed in Table 2.5. The final total volume of one PCR 
reaction is 50 μl, containing 1 x PCR reaction buffer, 1.5 mM MgCl2, 0.2 mM dNTP, 0.2 
pmol/μl of each forward primer and reverse primer and one unit Taq DNA polymerase. Taq 
DNA polymerase for PCR amplification was purchased from Invitrogen and the 10 mM 
deoxyribonucleotide triphophate (dNTP) stock solution was prepared from a 100 mM dNTP 
set purchased from Bioline by mixing all the four dNTP in equal proportions. Template DNA 
was prepared by spinning down overnight culture of bacteria in LB broth in microcentrifuge 
and resuspending within 1 ml sterile water, with 5 μl added to the reaction as template DNA 
for PCR.  
 
PCR reaction was performed using a gradient thermal Palm-Cycler™ (Corbett Life Science) 
and thermocycling conditions for a PCR reaction are shown in Table 2.6.  
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Table 2.6. Reagents of PCR reaction 
Reagent Volume (μl) Final Concentration 
10x PCR Running Buffer 5.0 1 x 
MgCl2 (50 mM) 1.5 1.5 mM 
dNTP (10 mM) 1 0.2 mM 
Forward Primer (10 μM) 1 0.2 μM 
Reverse Primer (10 μM) 1 0.2 μM 
Taq DNA Polymerase (5 U/μl) 0.2 1 U 
Template DNA 5 1 ~ 5 ng per 50 μl 
MilliQ H2O 35.3  
Total Volume 50  
 
Table 2.7. Standard PCR setup 
Stage Temperature Time Cycles 
Initial Denaturation 94 oC 3 min 1 
Denaturation 94 oC 45 sec  
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Annealing 56 oC 45 sec 
Elongation 72 oC 1 min per kb 
Final Elongation 72 oC 10 min 1 
Hold 4 oC - - 
 
For the separation of DNA fragments, amplified DNA samples were mixed with 6 x DNA 
gel loading dye (Thermo Fisher) at the ratio of 1:5 and then loaded into indentations of 1% 
agarose gel supplanted with 1X SYBRTM Safe DNA gel stain (Invitrogen). To estimate the 
length of DNA fragments, the ready-to-use GeneRuler 1kb DNA Ladder (Thermo Fisher) 
was also loaded onto the gel. Gel electrophoresis was carried out in 1 x TBE buffer 
(UltraPure™, Invitrogen) at 140 volts for 24 minutes. After DNA fragments were separated, 
we examined the gel by placing the gel under Ultraviolet (UV) light produced by a High-
Performance UV transilluminator, and thus DNA became visible. The photograph of gel 
was taken by using the DigiDoc-It Imaging Systems installed with Doc-It LS Image Analysis 






CHAPTER THREE: RESULTS 
3.1 Evolving P. fluorescens SBW25 on the surfaces of metallic copper 
This long-term research of experimental evolution forms the basis of the experimental work 
described in the following sections of this master’s thesis. This work was performed by 
previous researchers in Zhang’s lab, and results of a proof-of-concept study were 
published by Liu and Zhang (2016). 
 
As outlined in Figure 3.1, the work involved two treatments with and without copper contact 
killing. Eight independent evolutionary lines of strains were subject to continued selection 
on metallic copper, named as copper treatment strains (D1 to D8). As a control, strains 
were subject to serial daily transfer in the Luria-Bertani (LB) broth without copper treatment 
by 1000-times dilution in eight lines, named as control strains (C1 to C8). 320 transfers 
(around 3200 generations) were performed in total, with the first 200 transfers on a brass 
coupon (63.5% Cu) and the following 100 transfers on a pure copper coupon (99.99% Cu). 
 
 
Figure 3.1. Outline of the mutation accumulation experiment. P. fluorescens 
SBW25 was subjected to daily passage of sub-lethal conditions on the surfaces of 
brass or pure copper. For copper treatment line, bacterial cells from the overnight 
culture were washed once with sterile water, and then 20 μl added onto a metal coupon. 
After 60 min treatment at room temperature, all surviving cells on the coupon were 
suspended into 2 ml of fresh LB medium and subject to next round of copper treatment 
on the following day. In the control line, bacterial cells were subject to serial daily 
transfer in parallel without the treatment of contact killing on copper surfaces (Liu et al., 
2016). 
 
Bacterial cultures of every 10 transfers were stored in glycerol stock at -80 ℃ freezer and 
their ability to survive from contact killing on brass and pure copper was then determined. 
Results are shown in Figure 3.2 and survival rates of evolved strains from the 320th transfer 
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on copper are summarized in Table 3.1. Survival rates of strains from the control lines 
without copper treatment remained the low levels during the whole process of evolution. In 
the contrast, the survival rate of copper treatment lines increased from 0.035±0.001% to 
30.982±2.468% during the first 200 transfers on brass, and further increased to 
37.795±4.293% from the 320th transfer on pure copper.  
 
Genome of the evolved strains have been sequenced, and a comparison with genome 
sequence of the ancestral P. fluorescens SBW25 identified over 200 mutations. These 
included mutS associated with mutation rates, and many genes involved in pyoverdine 
production (data not shown). 
 
 
Figure 3.2. Dynamic changes in bacterial resistance to copper. A non-pathogenic 
strain of P. fluorescens SBW25 was subjected to daily passage of sub-lethal conditions 
(1-hour copper treatment) on the surface of brass during the first 200 transfers and on 
the surface of pure copper after 200 transfer. As a control, the LSWS-lacZ strain was 
subjected to the same treatment but without the copper. The survival rate was 
determined every 20 transfers.  
 
3.1.1 Examining bacterial susceptibility to copper ions  
To determine whether evolved strains display higher resistance to copper sulphate, we 
evaluated the minimal inhibitory concentration of copper ions (MIC-Cu2+) of all evolved 
strains, wild type SBW25 and mutants derived from SBW25. A cueA deletion mutant 
derived from SBW25 which showed a twofold reduction in its resistance to copper ions, 
referred to as ΔcueA, was used as a control in this study (Zhang & Rainey, 2006). 
 
Representative plate figures are shown in Figure 3.3 with results summarized in Table 3.1 
(and all images of 10-3, 10-4 and 10-2 dilutions are available in Appendix 1). The figures 
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clearly indicated that evolved copper treatment strains (D1 to D8), especially D3 and D4 
(MIC-Cu2+, 3750 μM), were more tolerant to copper ions than wild type SBW25. However, 
evolved control strains (C1 to C8) displayed the similar levels of resistance to copper ions 
when compared with the wide type ancestor, with a MIC value of 3250 μM. 
 
 
Figure 3.3. Representative plate photos for copper MIC tests. Concentration of CuSO4 
is indicated below each agar plate. For each strain, 10 μl of the diluted culture (10-4) was 
inoculated, and photos were taken after 48 hours incubation at 28 oC. 
 
3.1.2 Measuring pyoverdine production by the evolved strains 
Pyoverdine produced by Pseudomonas species is a yellow green fluorescent and high 
affinity siderophore responsible for iron transport, metabolism and heavy metal resistance 
system (Meyer, 2000; Hannauer et al. 2011). Comparison of the whole genome sequence 
of the ancestral SBW25 strain and copper treatment strains showed that metallic copper 
killing caused the mutation on several genes, pvsA, pvdj and pvdL, involved in pyoverdine 
synthesis in P. fluorescens. Thus, we decided to compare the pyoverdine production 
between evolved strains and wild type SBW25.  
 
In this work, a SBW25 mutant carrying the deletion of pvdL which displays a decreased 
ability to produce pyoverdine was included as a negative control (Zhang & Rainey, 2012). 
 
The results are summarized in Table 3.1. We first measured the pyoverdine production in 
LB medium after 24-hour and 48-hour incubation. The data for 48-hour incubation is shown 
in Figure 3.4 and the full dataset for both 24-hour and 48-hour incubation are available in 
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Appendix 2 - 3. Fluorescence was measured at 460 nm with an excitation wavelength at 
360 nm. Result showed that all copper treatment strains produced significantly less 
pyoverdine compared to wild-type SBW25 after 48-hour growth (P < 0.05) (Figure 3.4B). 




Figure 3.4. Pyoverdine production (RFU) by the evolved strains when grown in LB medium. 
Pyoverdine production of single colony strains (A) and their respective evolved population strains (B) 
was measured after 48-hour growth in LB medium. Data are means and standard errors of four 
biological replicates. Asterisks denote significant difference compared with wild-type SBW25 (P<0.05). 
The line in the middle of the box represents the median; the bottom and top boxes represent the 25th 
and 75th percentiles, respectively; and the lower and upper whiskers indicate the smallest and the 
largest values, respectively. Strains included in this assay: control strains from the 320th transfer of 
evolutionary experiment and their respective single colonies; copper treatment strains and their 
respective single colonies; wild type SBW25; SBW25 mutant with the deletion of pvdL gene. 
 
Next, we preformed pyoverdine production measurements in King’s B medium. King's B 
(KB) medium described by King et al. (1954) is a non-selective medium which can promote 
the production and excretion of pyoverdine.  
 
After 48 hours incubation, evolved control strains and wild type SBW25 produced 
characteristic green color while copper treatment strains showed only little greenish yellow 
fluorescent. As indicated in Figure 3.5, compared with wild type SBW25 strain, copper 
treatment strains displayed reduced fluorescence in the culture supernatant (Of note, all 
the details are available in Appendix 4 - 5). Significant but smaller difference was found 
between evolved control strains and SBW25. Single colonies of copper treatment strains 
showed the similar pattern to the respective evolved strains whereas among evolved 
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control strains, only single colonies of C1 and C2 produced significantly lower level of 
pyoverdine (RFU, 715.000 and 462.500, respectively, P<0.001). 
 
 
Figure 3.5. Pyoverdine production (RFU) by the evolved strains when grown in KB medium. 
Pyoverdine production of single colony strains (A) and their respective evolved population strains (B) 
was measured after 48-hour growth in KB medium. Data are means and standard errors of four 
biological replicates. Asterisks denote significant difference compared with wild-type SBW25 (P<0.05). 
The line in the middle of the box represents the median; the bottom and top boxes represent the 25th 
and 75th percentiles, respectively; and the lower and upper whiskers indicate the smallest and the 
largest values, respectively. Strains included in this assay: control strains from the 320th transfer of 
evolutionary experiment and their respective single colonies; copper treatment strains and their 
respective single colonies; wild type SBW25; SBW25 mutant with the deletion of pvdL gene.  
 
3.1.3 Using fluctuation test to determine mutation rate of the evolved strains 
The data of mutation rates is shown in Figure 3.6 and summarized in Table 3.1 (details are 
available in Appendix 6). Results of bz-rates clearly showed that compared with wild type 
SBW25, all evolved strains exhibited an average threefold increase in mutation rate. 
However, there is no significant difference between the mutation rates of evolved control 





Figure 3.6. Rates of mutation in evolved strains at 320th transfer and in their 
common ancestor SBW25. Mutation rate was determined by fluctuation test to 
nalidixic acid resistance and calculated by bz-rates web tool. Each bar represents six 
replicates per population. The line in the middle of the box represents the median; 
the bottom and top boxes represent the lower and upper 95% confidence limit. 
 
Table 3.1. A summary of phenotypic analysis of wild-type bacteria P. fluorescens 
SBW25 and the evolved strains. 















(MIC, μg/ml) LB KB 
C1 0.05 3250 208.000 13830.000 -6.41 1 
C2 0.04 3250 210.000 11897.500 -5.74 1 
C3 0.20 3250 146.500 11687.500 -5.85 1 
C4 0.14 3250 194.000 13245.000 -5.47 1 
C5 0.04 3250 158.500 12177.500 -5.86 1 
C6 0.07 3250 137.250 11750.000 -6.62 1 
C7 0.04 3250 187.750 11400.000 -6.11 1 
C8 0.17 3250 209.750 12830.000 -5.95 1 
D1 41.72 3500 39.000 8237.500 -5.62 2 
D2 47.79 3500 111.750 8907.500 -6.08 2 
D3 60.00 3750 62.000 130.000 -6.09 2 
D4 34.21 3750 58.500 160.000 -6.42 2 
D5 22.50 3500 116.000 3580.000 -5.91 2 
D6 38.75 3500 143.000 1175.000 -6.57 2 
49 
 
D7 30.93 3500 102.750 1740.000 -5.60 2 
D8 26.45 3500 89.500 1052.500 -5.28 2 
SBW25  3250 182.750 18045.000 -8.94 1 
ΔcueA  2500    1 
ΔpvdL  3250 115.750 175.0   
ΔmutS  3250    1 
ΔmutL  3250    1 
 
3.2 Exploring antimicrobial resistances to antibiotics and copper 
3.2.1 Using agar dilution method to determine the minimal inhibitory concentration 
(MIC) of antibiotics 
It might be argued that prolonged use of metallic copper surfaces in hospitals would not 
only select for resistance traits against copper but also would favor co-selection with innate 
antibiotic resistance genes. Therefore, in this work we investigated the probable 
overlapping antimicrobial resistance to copper and antibiotics by determining in vitro MIC 
of various types of antibiotics following agar dilution method (Wiegand et al., 2008).  
 
Antibiotics used in this study are listed in Table 2.3 with the receipts of their stock solution 
(See Methods). In total, we selected ten types of antibiotics from different classes varying 
in mechanisms of killing bacteria and all these antibiotics are commonly prescribed to 
human and highly utilized for medical use in hospitals to minimize diseases. LB agar plates 
were supplemented with the following concentrations of different antibiotics: 0, 0.06, 0.25, 
0.5, 1, 2, 4, 8, 16, 32, 64, 128, 256 μg/ml. 
 
All the results are summarized in Table 3.2 and photos are shown in Appendix 7. Wild type 
SBW25 shows natural resistance to carbenicillin (Cb), penicillin (Pen) and ampicillin (Amp). 
As the lacZ marker was inserted into the ancestral strain of evolution experiment through 
mini-Tn7 system, all evolved strains are tolerant to gentamicin (Gem). Thus, these four 
antibiotics are useless for examining the difference of antibiotic resistances between 
evolved strains and wild type SBW25. Although evolved copper treatment strains exhibited 
increased MIC of neomycin (Nm), nalidixic acid (Nal), tetracycline (Tet), streptomycin (Str), 
kanamycin (Km) and tobramycin (Tob) compared with SBW25, these results may be not 




It is interesting to note that the deletion of mutS and mutL gene for the DNA mismatch 
repair system and of cueA gene encoding a copper homeostasis P-type ATPase increased 
bacterial resistance to Str.  
 
Thus, we proceeded to subject the overnight bacterial cultures to 10-4 and 10-5 dilution 
and inoculate dilutions onto LB agar plates containing varying concentrations of Tob. As 
shown in Figure 3.7, evolved copper treatment strains were more resistant to Tob (MIC, 2 
μg/ml) whereas control strains showed similar MIC of Tob (1 μg/ml) to SBW25. This 
suggests that there was co-selection of metallic copper resistance and resistance against 
tobramycin. 
 
Table 3.2. Minimal inhibitory concentrations (MICs,μg/ml) of antibiotics for the 
evolved strains and mutants derived from SBW25. 
 Pen Cb Amp Nm Gem Nal Str Tet Km Tob 
C1 - - - 32 >256 64 32 8 16 8 
C2 - - - 32 256 64 32 8 16 8 
C3 - - - 32 >256 64 32 8 16 8 
C4 - - - 32 >256 64 32 8 16 8 
C5 - - - 32 >256 64 32 8 16 8 
C6 - - - 32 256 64 32 8 16 8 
C7 - - - 32 >256 64 32 8 16 8 
C8 - - - 32 256 64 32 8 16 4 
D1 - - - 64 >256 64 32 8 32 8 
D2 - - - 32 >256 64 32 8 16 8 
D3 - - - 64 >256 64 32 4 32 16 
D4 - - - 64 >256 64 32 8 32 16 
D5 - - - 64 >256 64 32 4 32 8 
D6 - - - 32 >256 64 32 4 16 8 
D7 - - - 32 >256 64 32 4 16 8 
D8 - - - 32 >256 64 32 4 16 8 
SBW25 - - - 16 4 16 8 8 4 2 
ΔmutS - - - 32 8 64 32    
ΔmutL - - - 32 8 32 32    





Figure 3.7. Representative photos for the sensitivity of P. fluorescens strains to tobramycin. 
Concentration of tobramycin is indicated below each agar plate. For each strain, 10 μl of the 
diluted culture (10-4) was inoculated, and photos were taken after 48 hours incubation at 28 oC. 
 
3.2.2 Determining bacterial resistance to tobramycin in broth medium 
To further investigate the potential overlapping antimicrobial resistances to copper and 
antibiotics, we assayed the growth of wild type SBW25 and the evolved strains in broth 
medium with varying concentrations of antibiotics. This work involved two types of broth 
medium: LB medium and M9 minimal medium with succinate (20 mM) as the sole carbon 
source and with histidine (10 mM) as the sole nitrogen source. We selected tobramycin 
(Tob) as the antibiotic tested in this assay.  
 
The full dataset is available in Appendix 9 - 10 for LB medium and Appendix 11 - 12 for M9 
minimal medium. In general, evolved copper treatment strains exhibited altered levels of 
resistance to Tob. More specifically, in LB medium, evolved copper treatment strains 
exhibited longer lag phase and higher yield than wild type SBW25 at 2 μg/ml Tob 
concentration, the condition under which wild type SBW25 showed a significantly reduced 
but not abolished growth (Figure 3.8A).  
 
In M9 medium with 2 μg/ml Tob, growth pattern of copper treatment lines was not 
significantly influenced whereas the growth of wild type SBW25 was fully inhibited (Figure 
3.9A). Interestingly, D7 and D8 was not grown even in fresh M9 medium without the 
supplementation of antibiotic (Figure 3.9A), and results of whole-genome sequencing 
showed that mutations occurred on genes responsible for histidine uptake and transport, 
such as hutF, cbrB and ntrBC, in these two strain lines.  
 
However, it should be noted that differences were also found between tobramycin 
resistance of evolved control strains and wild type SBW25: in LB medium and M9 medium 
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with 2 μg/ml Tob, evolved control strains except C5 grew well than SBW25 and exhibited 
higher resistance to Tob (Figure 3.8B and Figure 3.9B).  
 
A                                         B 
 
Figure 3.8. Growth kinetics of wild-type SBW25 and the evolved strains (A: copper 
treatment strains; B: control strains) in LB medium with tobramycin. The 
concentration of tobramycin is 0,1,2, 2.5 and 3 μg/ml. Data are means and standard errors 
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of 3 independent cultures. 
 
 
Figure 3.9. Growth kinetics of wild-type SBW25 and the evolved strains (A: copper 
treatment strains; B: control strains) in M9 minimal salt medium with tobramycin. 20 
mM succinate and 10 mM histidine are added into medium as the sole carbon source and 
nitrogen source, respectively. The concentration of tobramycin is 0,1 and 2 μg/ml. Data are 
means and standard errors of 3 independent cultures. 
 
3.2.3 Measuring fitness of the evolved strains relative to the wild-type ancestor 
To examine the possible impact of copper treatment on microbial antibiotic resistance, we 
further measured relative fitness of the evolved strains when they were grown in LB 
medium with and without Tob (2 μg/ml). 
 
The result was summarized in Figure 3.10. The full dataset is available in Appendix 13 for 
LB medium and Appendix 14 for LB medium with Tob. In unsupplemented LB, relative 
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fitness of evolved copper treatment strains to wild type SBW25 is lower than that of evolved 
control strains. In LB medium with subinhibitory concentration of Tob (2 μg/ml), relative 
fitness of copper treatment strains is greater than that of control strains. 
 
Taken together all the fitness assay data presented above, we can conclude that the 
copper evolved strains (D1 to D8) showed restively higher levels of resistance when 
compared with evolved strains without copper treatment (C1 to C8). 
 
 
Figure 3.10. Fitness of evolved strains in LB medium with and without 2 μg/ml 
tobramycin. Fitness of evolved strains was determined relative to the wild type SBW25 
after 24h growth in fresh LB medium or LB medium supplemented with 2 μg/ml 
tobramycin. Fitness data (mean and SEs of four biological replicates) are log10 
transformed ratios of the Malthusian parameters for each competitor. 
 
3.3 Evolution of bacterial resistance to ionic copper  
3.3.1 Broth-to-broth transfer 
In this work, broth-to-broth transfer relied on the stepwise cultivation of bacterial cells in LB 
media supplemented with subinhibitory concentrations of copper sulphate. To decide the 
initial copper concentration, we first measured the cell density of wild type P. aeruginosa 
MPAO1 and P. fluorescens SBW25 in LB broth supplemented with varying concentrations 
of copper sulfate. Based on this proof-of-concept study (Figure 3.11), the initial copper 
concentration of the broth-to-broth transfer was set up as 2.5 mM for SBW25 and 4 mM 
for MPAO1, which is permissive but subinhibitory for all strain lines. Also, we decided to 




Figure 3.11. Yield of P. aeruginosa MPAO1 and P. fluorescens SBW25 grown in LB broth 
supplemented with varying concentrations of copper sulphate. Absorbance (A600) was measured 
at 24 hrs and 48 hrs after inoculation. 
 
As outlined in Figure 3.12, broth-to-broth transfer started by growing six independent lines 
of MPAO1 and six lines of SBW25 in 5 ml LB broth and transferring 5 μl of the overnight 
bacterial cultures in LB medium supplemented with subinhibitory concentration of ionic 
copper. At each transfer, bacterial cultures were grown for 48 hours before next round of 
transfer. Every ten transfers, the concentration of ionic copper in LB medium was 
progressively increased. For SBW25, the starting condition was LB medium with 2.5 mM 
CuSO4 and the following steps were in LB medium with 3 mM CuSO4 and LB medium with 
3.25 mM CuSO4. For MPAO1, the stepwise conditions of broth-to-broth transfer were as 
follows: LB medium with 4 mM, 4.5 mM, 4.75 mM and 5 mM CuSO4. Treatment B was set 
up as a control for bacterial adaptation in the LB medium, which was performed in parallel 





Figure 3.12. Outline of experimental evolution by broth-to-broth transfer. A. For each 
transfer, 5 μl of bacterial cultures grown in 5 ml LB mediums was inoculated into 5 ml LB 
medium with subinhibitory concentration of ionic copper. 5 μl of the bacterial cultures will 
subject to the next round of transfer after two-day incubation. Every ten transfers, 
concentrations of copper sulphate added into LB medium will be progressively increased. 
B. A control without the supplement of ionic copper in LB broth. 
 
In this work, ancestral strains were marked with the lacZ marker through the mini-Tn7 
system, and thus, they form distinctive blue colonies on LB agar plates supplemented with 
X-Gal and 30 μg/ml Gem (Figure 3.13). These characters were used to verify the strain 
identity during the process of experimental evolution and ensure that there was no external 
microbial contamination. In addition, as each ancestral strain was marked with a unique 
lacZ promoter by electroporation, PCR amplification of each strain-specific gene was 
conducted to verify the strain identity and make sure that there was no cross contamination 
(Figure 3.14). It should be pointed out that during the course of transfer, one of control lines 
(EC line) was contaminated, and thus, there were only five control lines for SBW25 at the 
end of this work. 
 
 
Figure 3.13. Verification of P. fluorescens SBW25 and P. aeruginosa MPAO1 strains from 
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the 30th and 40th broth-to-broth transfer, respectively. Copper treatment cultures and 
control cultures were inoculated onto LB plus X-Gal plates supplemented with 30 μg/ml Gem 
by streaking. On each plate, the respective ancestral strain was used as the negative control. 




Figure 3.14. PCR verification of each strain line from broth-to-broth transfer. Each 
unique gene fragment was amplified by PCR using six pairs of primers. Gel electrophoresis 
was performed in 1 x TBE buffer at 140 volts using GeneRuler DNA ladder. Lane M, 
GeneRuler DNA ladder (1kb). (A), A30. Lane 1 is amplified by primers PhutuJ and lacz7. 
(B), B30. Lane 2 is amplified by PhutuF-F and lacz7. (C), C30. Lane 3 is amplified by PntrB-
1 and lacz7. (D), D30. Lane 4 is amplified by cbrA-FB and lacz7. (E), E30. Lane 5 is amplified 
by cbrB-FB and lacz7. (F), F30. Lane 6 is amplified by plc-R and lacz7. (G), a40. Lane 1 is 
amplified by primers PhutuJ and lacz7. (H), b40. Lane 2 is amplified by PhutuF-F and lacz7. 
(I), c40. Lane 3 is amplified by PntrB-1 and lacz7. (J), d40. Lane 4 is amplified by cbrA-FB 
and lacz7. (K), e40. Lane 5 is amplified by cbrB-FB and lacz7. (L), f40. Lane 6 is amplified 
by plc-R and lacz7. 
 
Bacterial cultures of every 10 transfers were stored in glycerol stock at -80℃ freezer and 
their tolerance towards copper ions was measured at the end of this work. Results are 
summarized in Table 3.3 with all plate photos available in Appendix 17 and 18. Strains from 
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the copper treatment line (referred to as a40 - f40 for the 40th evolutional MPAO1 and A30 
- F30 for the 30th evolutional SBW25) tolerated up to higher concentrations of ionic copper. 
In the contrast, the MIC-Cu2+ of strains from the control line (without copper treatment, 
referred to as ac-40 - fc40 for the 40th evolutional MPAO1 and AC30 – FC30 for the 30th 
evolutional SBW25) remained the similar levels to wild type ancestral strain after the whole 
































Table 3.3. Minimal inhibitory concentrations (MICs) of copper sulphate for the 
evolved strains by broth-to-broth transfer. As EC line was contaminated during broth-
to-broth transfer, MIC of EC30 was not measured. 
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P. aeruginosa 
















3.3.2 Colony-to-colony transfer using the gradient-plate method 
To determine the initial concentration of copper ions for colony-to-colony transfer, we first 
prepared gradient LB agar plates with the following concentrations of copper sulfate: 4 mM, 
5 mM, 6 mM and 7 mM and inoculated MPAO1 and SBW25 onto gradient plates.  
 
On the gradient LB agar plate with 6 mM copper ions and then inoculated with MPAO1, 
two distinct regions were observed after 48-hour incubation: an area of continuous dense 
growth and an area of discrete colonies (Figures are available in Appendix 19). Compared 
with the plate prepared two days before inoculation, there were more single colonies on 
the LB agar plate prepared only one day before inoculation. Similar results were obtained 
after three-day incubation on the gradient plate with 5 mM copper ions and inoculated with 
SBW25 (available in Appendix 19). Therefore, we set up the initial concentration as 5 mM 
ionic copper for SBW25 and 6 mM for MPAO1 and decided to prepare the gradient plates 
one day before inoculation. 
 
For the colony-to-colony transfer, we followed the steps outlined in Figure 3.15. In brief, 
100 μl overnight bacterial cultures of six independent strain lines were spread out onto 
gradient plates with copper ions. After several days, a discrete mutant colony was picked 
and inoculated into fresh LB broth following purification onto LB plus X-Gal plate. The 













B. P. fluorescens SBW25 








C. P. aeruginosa MPAO1 
 





Figure 3.15. Colony-to-colony transfer performed on gradient LB agar plates.  
(A) Outline of colony-to-colony transfer. 100 μl of the overnight bacterial cultures was spread 
onto gradient LB agar plate containing CuSO4 prepared 24h before inoculation and then 
incubated until mutants grew. Then a single colony from gradient plate was picked and purified 
on LB plus X-Gal plate by streaking. After purification, a colony was inoculated into 5 ml LB 
broth and overnight bacterial culture was subject to the next round of colony-to-colony transfer. 
In total, 10 and 20 transfers were performed on SBW25 and MPAO1, respectively. 
(B) Mutants of SBW25 on gradient plates during colony-to-colony transfer. Concentration of 
CuSO4 is indicated on the corner of each agar plate. In total, SBW25 lines were subject to 10 
transfers. The colony picked for the next round of transfer and stored in -80 oC freezer was 
circled. 
(C) Mutants of MPAO1 on gradient plates during colony-to-colony transfer. Concentration of 
CuSO4 is indicated on the corner of each agar plate. In total, MPAO1 lines were subject to 20 





All evolved strains of every transfer were stored in glycerol stock at -80 ℃ freezer. At the 
end of this experimental work, we preformed PCR (Figure 3.17) and streaked the bacterial 
cultures onto LB plus X-Gal plates with 30 μg/ml Gem (Figure 3.16) to verify the strain 
identity. However, the 10th evolutional BP line was wrong as it was amplified by the pair of 
primers of EP line (Figure 3.17B). By conducting PCR on previous strains of BP line, we 




Figure 3.16. Verification of P. fluorescens SBW25 and P. aeruginosa MPAO1 strains 
obtained from the 10th and 20th colony-to-colony transfer, respectively. Copper 
treatment cultures and control cultures were inoculated onto LB plus X-Gal plates 
supplemented with 30 μg/ml Gem by streaking. On each plate, the respective ancestral 
strain was used as the negative control. SBW25 was incubated at 28 ℃ for two days and 
MPAO1 was incubated at 37 ℃ for one day. 
 
 
Figure 3.17. PCR verification of each strain line from colony-to-colony transfer. Each 
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unique gene fragment was amplified by PCR using six pair of primers. Gel electrophoresis was 
performed in 1 x TBE buffer at 140 volts using GeneRuler DNA ladder (1kb). Lane M, GeneRuler 
DNA ladder. (A), AP10. Lane 1 is amplified by primers PhutuJ and lacz7. (B), BP10. Lane 5 is 
wrong as it is amplified by cbrB-FB and lacz7. (C), CP10. Lane 3 is amplified by PntrB-1 and 
lacz7. (D), DP10. Lane 4 is amplified by cbrA-FB and lacz7. (E), EP10. Lane 5 is amplified by 
cbrB-FB and lacz7. (F), FP10. Lane 6 is amplified by plc-R and lacz7. (G), ap20. Lane 1 is 
amplified by primers PhutuJ and lacz7. (H), bp20. Lane 2 is amplified by PhutuF-F and lacz7. 
(I), cp20. Lane 3 is amplified by PntrB-1 and lacz7. (J), dp20. Lane 4 is amplified by cbrA-FB 
and lacz7. (K), ep20. Lane 5 is amplified by cbrB-FB and lacz7. (L), fp20. Lane 6 is amplified 
by plc-R and lacz7. 
 
Finally, in this work, we have also conducted an experiment to assay the tolerance towards 
ionic copper of evolved strains from the colony-to-colony transfer (referred to as AP10 - 
FP10 for the 10th evolutional SBW25 and ap20 – fp20 for the 20th evolutional MPAO1). 
Overnight cultures of all strain lines were subject to 10-3, 10-4 and 10-5 dilution before 
inoculation. Results are summarized in Table 3.4 and plate photos are available in 
Appendix 20 and 21. We observed that evolved MPAO1 strains and evolved SBW25 
strains obtained from colony-to-colony transfer were able to proliferate up to at least 3.9 





Table 3.4. Minimal inhibitory concentrations (MICs) of copper sulphate for the 
evolved strains by colony-to-colony transfer. 
Strain Resistance to ionic 





















CHAPTER FOUR: DISCUSSION 
4.1 Evolution of bacterial resistance to metallic copper 
HAIs are a serious public health problem worldwide and a novel strategy for HAI prevention 
is to apply antimicrobial metallic copper surfaces within hospitals. Given the expenses of 
introduction of copper surfaces, it is essential to conduct risk assessment, to optimize the 
handling of copper surfaces and avoid the potential evolution of metallic copper resistant 
pathogens. To examine the evolutionary effects of long-term contacts with copper surfaces 
on bacterial resistance, previous researchers in our lab conducted an evolution experiment 
on metallic copper. This experimental evolution allowed us to investigate physiological 
differences involved in acquired copper tolerance that we briefly summarize and discuss 
in the following.  
 
There has been no doubt that copper ions play a major role in the process of bacterial 
contact killing on metallic copper. Recent research demonstrated that defense systems 
against copper ions are attributable to the survival of bacteria on copper cast alloys in P. 
aeruginosa (Elguindi et al., 2009). Previous work showed that in most case, MIC scores of 
copper ions are positively correlated with survival rate on metallic copper (Liu & Zhang, 
2016). We therefore reasoned that evolved strains with higher survival rate on metallic 
copper are more tolerant to ionic copper. Our own data presented in this study showed that 
evolved copper treatment strains exhibited higher MIC of copper ions when compared with 
wild type SBW25.  
 
When measuring MIC-Cu2+, we first inoculated overnight bacterial cultures subjected to 
serial 100-fold dilution onto LB agar plates supplanted with the following ionic copper 
concentrations: 1.5, 1.75, 2.0, 2.5, 3.0, 3.5, 3.6, 3.7, 3.75, 3.8, 3.85, 3.9, 3.95, 4.0, 4.1, 4.2, 
4.3, 4.4, 4.5, 4.6, 4.7, 4.8, 4.9, 5.0, 5.1 mM. MIC-Cu2+ units were determined after 
incubated three days. However, results were complicated by the rise of spontaneous 
mutants in evolved strains due to the passage of long-term experimental evolution (Figures 
are available in Appendix 1).  
 
As the mutation rate is constant, we decided to subject the overnight bacterial cultures to 
serial 1000-fold and 10000-fold dilution to reduce the number of inoculated bacterial cells, 
thus minimizing the interference of mutants on the measurement of MIC-Cu2+. Also, 
considering that bacteria forms bacterial lawn whereas mutants form single colonies under 
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the inhibitory concentration, we monitored the growth statuses and took photos from day 
one to day three after inoculation. Thirdly, the standardization of the number of bacterial 
cells used for susceptibility testing is critical for obtaining accurate and reproducible results. 
Thus, concentration of copper ions was set up starting from 0μM. 
 
High mutation rates have been reported in Escherichia coli undergoing experimental 
evolution (Sniegowski, et al., 1997). Furthermore, it has been established that chronic 
exposure to sublethal levels of a metal can substantially increase the rate at which large-
scale heritable mutations arise in genomes (Chain et al., 2019). Armed with the knowledge 
that metal stress can impair DNA replication and DNA repair system (Baer et al., 2007), we 
then assayed for spontaneous mutation rates in the common ancestral strain SBW25 and 
in the evolved strains by the fluctuation test for nalidixic acid resistance. Consistent with 
previous research, our results illustrated that evolved strains were associated with higher 
mutation rates than ancestral strain, with around triple the rates of mutation. 
 
In this work, we also identified decreased pyoverdine production subsequent to long-term 
copper treatment. Previous research by Zhang and Rainey (2012) has shown that strains 
defective in pyoverdine production gained advantage under the conditions where 
pyoverdine was not required and another research by Jin et al. (2018) demonstrated that 
P. aeruginosa suppressed secretion of pyoverdine and accumulated pyoverdine in the 
periplasm when exposed to environmental stresses. One explanation might be that the 
pyoverdine-mediated iron uptake results in oxidative stress and thus kills cells faster in the 
presence of copper ions. 
 
4.2 Overlapping antimicrobial mechanisms of antibiotics and metallic 
copper 
Copper has been domestically used for thousands of years. Applying copper surfaces with 
antimicrobial activities onto surfaces commonly touched in hospital facilities, such as 
doorknobs and toilet seats will certainly be a significant economic commitment. However, 
there is a chance that introduction of copper alloys may facilitate multi drug resistance, 
resulting in the failure of medical antibiotic treatment and other hospital hygiene controls. 
Considering that possible impacts of metallic copper on the medical use of antibiotics have 
rarely been explored, it is critically important to analyse the potential impact of copper alloys 




Minimum inhibition concentrations are the gold standards in determining the susceptibilities 
of bacteria to antibiotics and other antimicrobial drugs. There are two general methods 
reported in literature for assaying MIC: agar dilution method and broth dilution method 
(Wiegand et al., 2007). In this work, we first measured MIC using agar dilution method. 
However, the mutation rates of evolved strains are significantly increased; thus, it is not 
appropriate to compare MIC of evolved strains with wild type SBW25 without sufficient 
dilution, and it would be technically difficult due to the large amount of manual handling 
needed to run the test. Thus, we decided to compare the growth curve under different 
concentrations of antibiotics. 
 
Tobramycin displays a narrow spectrum of activity similar to gentamicin, but is less 
nephrotoxic. Tobramycin works by preventing the formation of 70S complex and thus 
blocking the translation of mRNA (Haddad et al., 2002). Tobramycin is especially effective 
against species of Pseudomonas and consequently is commonly prescribed to treat cystic 
fibrosis associated with P. aeruginosa infection. Therefore, we selected tobramycin in this 
part of work. 
 
We found that copper treatment strains still grew well in mediums with inhibitory 
concentration of tobramycin. Although control strains could be cultured under inhibitory 
concentration of tobramycin, they exhibited different changes in growth patterns compared 
with copper treatment strains. For example, in LB medium with 2μg/mL tobramycin, most 
evolved copper treatment strains showed a significant lag phase extension while lag phase 
of evolved control strains was not altered. Previous research indicated that extension in 
the lag-time allows bacteria to survive under high antibiotic concentrations and 
accommodate the selective antibiotic pressures as an advantageous trait (Fridman et al., 
2014; Li et al., 2016). Hence, we can suggest that altered levels of resistance to tobramycin 
of copper treatment strains results from long-term copper contact rather than other 
spontaneous mutations occurring during the experimental evolution. Additionally, the 
difference between growth patterns in different mediums may be due to changes in fitness 
of the populations relative to their ancestral strain. Taken together, our data support the 
overlapping antimicrobial resistance to copper and tobramycin. 
 
4.3 Evolution of bacterial resistance to ionic copper 
In addition to its use as a commonly touch surface in healthcare settings, the antimicrobial 
effect of copper is being exploited in liquids and potent liquid formulations containing 
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copper ions might therefore be of potential use to control the spread of pathogens found in 
the healthcare environment responsible for HAIs. Recently, the biocidal effects of several 
copper-based liquid formulations have been assessed, confirming their efficacy against 
organisms highly relevant to HAIs (Gant et al., 2007). However, there may be chance that 
pathogens can evolve resistance to ionic copper due to large-scale application of these 
copper-based liquid formulations. In addition, considering the essential role of copper ions 
in copper contact killing, it is crucial to assess the potential of bacterial pathogens to 
develop resistance to copper ions. In this work, we have conducted an experimental 
evolution to examine the evolutionary effects of long-term subinhibitory concentration of 
copper ions on bacterial resistance to ionic copper and potential resistance to metallic 
copper and antibiotics. This part of work involves broth-to-broth transfer and colony-to-
colony transfer on copper gradient agar plate. While this work is currently ongoing, our 
primary data indicates that bacteria has evolved higher resistance to copper ions compared 






CHAPTER FIVE: CONCLUSION AND FUTURE RESEARCH 
 
5.1 Evolved strains show different functional traits associated with the evolution of 
copper resistance 
Copper and copper alloys exhibit intrinsic antimicrobial activities to a wide range of 
pathogens and consequently, have a great potential in reducing the incidence of hospital-
acquired infections (HAIs) when applied to commonly touched surfaces in healthcare 
settings such as door handle, pushing plate and toilet seats. However, there is a concern 
about the emergence of copper-resistant pathogens. 
 
Previous researchers in Zhang’s lab conducted experimental evolution, whereby eight 
independent lines of the non-pathogenic model bacterium – P. fluorescens SBW25 marked 
with a lacZ gene were daily treated with brass or pure copper for a period of 320 days in 
total. The data of rate of contact killing indicates that the evolved strains exhibit an increase 
of resistance to metallic copper. In this work, phenotypic characterization shows that all 
evolved strains subjected to long-term metallic copper treatment have enhanced mutation 
rate and decreased abilities to produce pyoverdine. Also, evolved copper treatment strains 
are more tolerant to ionic copper. This result suggests overlapping mechanisms conferring 
metallic and ionic copper resistances. 
 
5.2 Resistance to metallic copper is overlapped with resistance to tobramycin. 
Data of agar dilution method presented in this thesis indicates that evolved copper 
treatment strains have increased MIC of tobramycin compared with wild type SBW25. In 
addition, results of growth curve show that evolved copper treatment strains exhibit altered 
levels of resistance to tobramycin. All these data support the overlapping antimicrobial 
resistance to copper and tobramycin. 
  
5.3 Bacteria has evolved increased resistance to copper ions through evolutionary 
experiment 
Given the important role of copper ions in copper contact killing, it is critically important to 
assess the potential of bacterial pathogens to develop resistance to ionic copper and 
analyse physiological and genomic changes enabling bacterium to survive under sub-lethal 
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concentrations of copper ions. 
 
In this work, we have subjected a non-pathogenic model bacterium P. fluorescens SBW25 
and a common nosocomial pathogenic bacteria P. aeruginosa MPAO1 to a long-term 
experimental evolution, including broth-to-broth transfer and colony-to-colony transfer 
whereby bacterial cells were treated with sub-inhibitory concentration of copper ions in LB 
broth and on LB agar plates, respectively. Our primary data suggests that all the evolved 
copper treatment strains show an increased resistance to copper ions when compared with 
ancestral strains.  
 
5.4 Future research 
In this thesis, we have tested the potential of pathogens to develop resistance to metallic 
copper using experimental evolution and examined several functional traits associated with 
the evolution of copper resistance. Our data indicates the increased rate of mutation in 
evolved strains, perhaps resulting from the defects in their ability to repair DNA caused by 
copper contact killing. However, direct evidence on reactions between DNA and metallic 
copper are still lacking. Visualization of the DNA damages caused by contact killing can 
potentially be achieved using comet assay (Singh et al., 1988). Also, we observed that 
long-term contact with copper surfaces reduced pyoverdine production of SBW25. To 
better understand the role of pyoverdine in copper contact killing, we can compare the 
death rate of mutant defective in pyoverdine production on copper surface with SBW25 
following the wet incubation method (Warnes & Keevil, 2011). 
 
Secondly, we have examined the resistance to tobramycin of the evolved strains and 
explored possible correlation with resistance to metallic copper. Although it can be 
concluded from my thesis that copper resistance is associated with tobramycin resistance, 
we have not tested whether this is true for other antibiotics. Therefore, future work will first 
involve the analysis of growth curve of evolved strains when exposed to other antibiotics 
and Epsilometer test by using ready-to-use antibiotic stripes to measure antibiotic MIC 
(Glupczynski et al., 1991). Also, we can measure the growth curve of evolved copper 
treatment strains in M9 medium with other nitrogen source, such as ammonium chloride. 
 
Finally, we have used the experimental evolution to examine the potential of a pathogenic 
bacteria of P. aeruginosa PAO1 and a model organism of P. fluorescens SBW25 to develop 
resistance to copper ions. During the course of broth-to-broth transfer, even when the 
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concentration of copper ions is same as last transfer, bacterial cells may be not capable of 
growing. It is assumed that bacterial cells might undergo the viable but nonculturable 
(VBNC) condition occurring in response to adverse circumstances. To determine cell status, 
we can use the Live/Dead BacLight bacterial viability kit methodologies with fluorescent 
microscopy (Ordax et al., 2006). 
 
While promising results for experimental evolution have already been obtained in this 
thesis, it should be noted that the experimental evolution work has only been performed 
for around four months in total due to the time limit of my master program. Consequently, 
the long-term experimental evolution work initiated in this work to develop bacterial 
resistance to ionic copper is still ongoing in Zhang’s lab. According to the original 
experimental design, extensive genotypic and phenotypic characterizations will be 
performed with the evolve strains at the end of this experiment (e.g. after 50th transfer for 
colony-to-colony transfer and 100th transfer for broth-to-broth transfer). More specifically, 
whole genome sequencing will be used to identify the mutations accumulated during the 
process of experimental evolution and characterization of their functionalities will be 
performed. Together, it is anticipated that new data from longer term experimental evolution 
will help us better understand the mechanisms of bacterial resistance to antimicrobial 
metallic copper surfaces and evaluate the potentials of bacterial resistance to antimicrobial 
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Appendix 1. Plate photos for copper MIC tests. The layout of strains is shown in the 
figure above agar plates. Concentration of CuSO4 is indicated below each agar plate. 
Overnight bacterial cultures were subjected 10-2, 10-3 and 10-4 dilution, and 10 μl was 





Appendix 2. Pyoverdine production (RFU) of evolved strains after 24-hour and 48-
hour growth in LB medium. Data are means and standard errors of four biological 
replicates. Strains included in this assay: evolved control strains from the 320th transfer of 
evolutionary experiment and their respective single colonies; evolved copper treatment 
strains and their respective single colonies; wild type SBW25; SBW25 mutant with the 
deletion of pvdL gene. 
 
Strain 24h 48h 
population single colony population single colony 
C1 108.250 52.750 208.000 140.750 
C2 102.000 27.250 210.000 132.750 
C3 55.250 70.500 146.500 127.500 
C4 87.500 46.250 194.000 126.000 
C5 56.750 32.250 158.500 107.500 
C6 38.500 88.250 137.250 137.500 
C7 78.250 74.250 187.750 102.000 
C8 86.750 84.500 209.750 122.000 
D1 25.000 129.250 39.000 127.750 
D2 78.750 83.750 111.750 122.250 
D3 1.000 26.000 62.000 67.500 
D4 3.000 34.500 58.500 77.250 
D5 74.250 84.750 116.000 122.000 
D6 81.750 85.250 143.000 112.250 
D7 52.250 59.500 102.750 71.750 
D8 57.250 44.000 89.500 70.750 
Wild type SBW25 44.500 122.250 182.750 182.750 







Appendix 3. Pyoverdine production (RFU) of evolved strains after 24-hour in LB 
medium. Data are means and standard errors of four biological replicates. The line in the 
middle of the box represents the median; the bottom and top boxes represent the 25th and 
75th percentiles, respectively; and the lower and upper whiskers indicate the smallest and 
the largest values, respectively. Strains included in this assay: evolved control strains from 
the 320th transfer of evolutionary experiment and their respective single colonies; evolved 
copper treatment strains and their respective single colonies; wild type SBW25; SBW25 








Appendix 4. Pyoverdine production (RFU) of evolved strains after 24-hour and 48-
hour growth in KB medium. Data are means and standard errors of four biological 
replicates. Strains included in this assay: evolved control strains from the 320th transfer of 
evolutionary experiment and their respective single colonies; evolved copper treatment 
strains and their respective single colonies; wild type SBW25; SBW25 mutant with the 
deletion of pvdL gene. 
 
Strain 24h 48h 
population single colony population single colony 
C1 4602.50 165.000 13830.000 715.000 
C2 3662.50 95.000 11897.500 462.500 
C3 3752.50 9962.500 11687.500 18025.000 
C4 3972.50 9245.000 13245.000 17455.000 
C5 3320.00 11025.000 12177.500 16130.000 
C6 3772.50 12040.000 11750.000 19700.000 
C7 4950.00 15372.500 11400.000 19942.500 
C8 3917.50 11027.500 12830.000 18150.000 
D1 3875.00 10190.000 8237.500 14472.500 
D2 6340.00 9310.000 8907.500 13522.500 
D3 72.50 87.500 130.000 52.500 
D4 87.50 90.000 160.000 172.500 
D5 3922.50 3320.000 3580.000 5510.000 
D6 362.50 175.000 1175.000 585.000 
D7 1480.00 1887.500 1740.000 2860.000 
D8 800.00 1452.500 1052.500 2912.500 
Wild type SBW25 6257.50 15725.000 18045.000 21200.000 












Appendix 5. Pyoverdine production (RFU) of evolved strains after 24-hour growth 
in KB medium. Data are means and standard errors of four biological replicates. The 
line in the middle of the box represents the median; the bottom and top boxes represent 
the 25th and 75th percentiles, respectively; and the lower and upper whiskers indicate 
the smallest and the largest values, respectively. Strains included in this assay: evolved 
control strains from the 320th transfer of evolutionary experiment and their respective 
single colonies; evolve copper treatment strains and their respective single colonies; wild 






Appendix 6. Rates of mutation in evolved control strains and copper treatment 
experimental populations (C1 to C8 and D1 to D8) at 320th transfer and in their 
common ancestor SBW25. 
 




C1 3.8816490E-07 1.48E-07 6.29E-07 
C2 1.81276990E-06 8.64E-07 2.76E-06 
C3 1.4196642E-06 6.10E-07 2.23E-06 
C4 3.38072620E-06 1.51E-06 5.25E-06 
C5 1.3808108E-06 6.46E-07 2.12E-06 
C6 2.3736020E-07 9.99E-08 3.75E-07 
C7 7.8047210E-07 4.36E-07 1.13E-06 
C8 1.1151465E-06 4.96E-07 1.73E-06 
D1 2.37696200E-06 1.26E-06 3.49E-06 
D2 8.289661E-07 1.44E-07 1.51E-06 
D3 8.1972300E-07 4.91E-07 1.15E-06 
D4 3.8412940E-07 1.47E-07 4.48E-07 
D5 1.2397308E-06 6.33E-07 1.85E-06 
D6 2.7215160E-07 1.15E-07 4.29E-07 
D7 2.4899151E-06 9.89E-07 3.99E-06 
D8 5.26879720E-06 2.93E-06 7.61E-06 
Wild type 
SBW25 























Appendix 7. Plate photos for antibiotic MIC tests. The layout of strains on LB agar 
plates supplemented with penicillin, carbenicillin, ampicillin, neomycin, gentamicin, 
streptomycin and nalidixic acid is shown in (A) and with tetracycline, kanamycin, 
tobramycin in (B). Concentration of antibiotic (μg/ml) is indicated on the corner of each 
agar plate. Overnight bacterial cultures were subjected 10-2 dilution, and 10 μl was dropped 
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Appendix 8. Plate photos for tobramycin MIC tests. The layout of strains is shown in 
the figure above agar plates. Concentration of tobramycin is indicated below each agar 
plate. Overnight bacterial cultures were subjected to 10-4 and 10-5 dilution, and 10 μl was 


















Appendix 9. Growth kinetics of wild-type SBW25 and evolved control strains in LB 
medium. LB medium was supplemented with 0, 1, 2, 2.5 and 3 μg/ml tobramycin. Data 













Appendix 10. Growth kinetics of wild-type SBW25 and evolved copper treatment 
strains in LB medium. LB medium was supplemented with 0, 1, 2, 2.5 and 3 μg/ml 








Appendix 11. Growth kinetics of wild-type SBW25 and evolved control strains in 
M9 minimal salt medium. 20 mM succinate and 10 mM histidine are added into medium 
as the sole carbon source and nitrogen source, respectively. The concentration of 
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Appendix 12. Growth kinetics of wild-type SBW25 and evolved copper treatment 
strains in M9 minimal salt medium. 20 mM succinate and 10 mM histidine are added 
into medium as the sole carbon source and nitrogen source, respectively. The 
























Appendix 13. Fitness of evolved strains in LB medium. Fitness of evolved strains 
was determined relative to the wild type SBW25 after 24h growth in fresh LB medium. 
Fitness data (mean and SEs of four biological replicates) are log10 transformed ratios of 
the Malthusian parameters for each competitor. 
 
 Replicate 1 Replicate 2 Replicate 3 Replicate 4 
C1 -0.254169 -1.6171519 -0.4285716 -0.6184181 
C2 -0.1686227 -0.4405564 0.06334875 0.19229852 
C3 -0.5281049 -0.7021048 -0.6539265 -0.7037743 
C4 -0.3629737 -0.6410063 -0.3657248 -0.4178262 
C5 -0.3106773 -0.1055403 -0.2549437 -0.6655902 
C6 -0.2101136 -0.8127467 -0.0943528 0.07351069 
C7 1.15199865 1.42232502 0.95547257 0.79812466 
C8 0.02120221 -0.3928466 -0.0084096 -0.6386590 
D1 -0.8746031 -1.0596837 -0.9571503 -0.9297589 
D2 -2.3237823 -2.9093735 -2.6415673 -2.4238438 
D3 -1.9808079 -3.3015846 -2.9986350 -1.9676814 
D4 -3.2633095 -3.8345669 -2.8781291 -2.5085647 
D5 -2.5518558 -2.9599362 -2.7974173 -2.3065294 
D6 -1.6879504 -1.6197065 -1.8458534 -1.5795298 
D7 -3.6557106 -3.5276778 -4.9675933 -4.7780166 
















Appendix 14. Fitness of evolved strains in LB medium with 2 μg/ml tobramycin. 
Fitness of evolved strains was determined relative to the wild type SBW25 after 24h 
growth in LB medium supplemented with 2 μg/ml tobramycin. Fitness data (mean and 
SEs of four biological replicates) are log10 transformed ratios of the Malthusian 
parameters for each competitor. 
 
 Replicate 1 Replicate 2 Replicate 3 Replicate 4 
C1 4.36004773 4.08561088 2.98699859 4.25468721 
C2 3.76897485 3.63794659 4.55022930 4.71635617 
C3 3.88106078 4.43255744 4.57042724 4.55515977 
C4 4.76983681 3.88253361 4.15823949 4.96514556 
C5 4.51847496 4.26619482 4.68031799 4.34154426 
C6 4.05717580 4.15380263 4.60219278 4.29534280 
C7 3.55950607 4.40388422 4.29265859 2.65336771 
C8 3.65610521 4.18518427 4.16165377 4.34044176 
D1 7.39659645 6.64111754 7.35276473 6.59873832 
D2 5.90991949 6.17439866 7.41908078 6.47084503 
D3 6.21264524 5.61294276 6.00307655 6.15642434 
D4 7.23291376 8.00269416 8.74774920 7.05940283 
D5 6.91007816 6.88422478 6.10666026 6.58697326 
D6 5.46806014 5.75574221 5.94433338 4.68274250 
D7 5.63788126 6.09230096 5.91446779 6.09230096 










Appendix 15. PCR verification of the integration of Mini-Tn7 element carrying lacZ 
fusion in P. aeruginosa MPAO1. To verify integration of the mini-Tn7 element into the 
unique chromosomal integration sites located downstream of glmS gene. P. aeruginosa 
MPAO1 transconjugants were subjected to PCR amplification using the forward primer 
MLG048-PF and the reverse primer MLG049-PR. Gel electrophoresis was performed in 
1x TBE buffer at 140 volts using GeneRuler DNA ladder (1kb). DNA was visualized under 
UV lights. Lane M in (A) and (B), GeneRuler DNA ladder purchased from Thermo 
Scientific Ltd (Auckland). Lane 1-3 in (A), cultures of bacteria marked with PhutuJ-lacZ, 
PhutF-lacZ and PntrB-lacZ. Lane 1-3 in (B), cultures of bacteria marked with PcbrA-lacZ, 
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Appendix 16. Blue colonies formed by the 30th evolutional SBW25 strain and the 
40th evolutional MPAO1 strain from broth-to-broth transfer. Bacterial cultures were 
inoculated onto LB plus X-Gal (40 μg/ml) plates by streaking. SBW25 was incubated at 28℃ 
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Appendix 17. Plate photos for copper MIC tests for the evolved SBW25 strains 
from broth-to-broth transfer. The layout of strains is shown in the figure above agar 
plates. Concentration of CuSO4 is indicated below each agar plate. The overnight 
bacterial cultures were subjected to 10-3 and 10-4 dilution, and 10 μl was dropped onto an 
agar plate. Photos were taken after 24, 48 and 72-hour incubation. Minimal inhibitory 
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Appendix 18. Plate photos for copper MIC tests for the evolved MPAO1 strains 
from broth-to-broth transfer. The layout of strains is shown in the figure above agar 
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plates. Concentration of CuSO4 is indicated below each agar plate. The overnight 
bacterial cultures were subjected to 10-3 and 10-4 dilution, and 10 μl was dropped onto an 
agar plate. Photos were taken after 24 and 48-hour incubation. Minimal inhibitory 








Day1             Day2            Day3 
 
Appendix 19. Distribution of colonies on gradient LB agar plates with ionic copper. 
To decide the experiment condition of colony-to-colony transfer, plates were prepared 24h 
and 48h before inoculation. MPAO1 and SBW25 was inoculated onto gradient LB agar 
plate supplemented with 6 mM and 5 mM copper ions, respectively. The growth statuses 
of MPAO1 were recorded from day one to day three at 37 ℃ while the growth statuses of 
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Appendix 20. Plate photos for copper MIC tests for the evolved SBW25 strains 
from colony-to-colony transfer. The layout of strains is shown in the figure above agar 
plates. Concentration of CuSO4 is indicated below each agar plate. The overnight 
bacterial cultures were subjected to 10-3,10-4 and 10-5 dilution, and 10 μl was dropped 
onto an agar plate. Photos were taken after 24, 48 and 72-hour incubation. Minimal 
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Appendix 21. Plate photos for copper MIC tests for the evolved MPAO1 strains 
from colony-to-colony transfer. The layout of strains is shown in the figure above agar 
plates. Concentration of CuSO4 is indicated below each agar plate. The overnight 
bacterial cultures were subjected to 10-3, 10-4 and 10-5 dilution, and 10 μl was dropped 
onto an agar plate. Photos were taken after 24, 48 and 72-hour incubation. Minimal 
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